<SEC-DOCUMENT>0001333493-25-000083.txt : 20250729
<SEC-HEADER>0001333493-25-000083.hdr.sgml : 20250729
<ACCEPTANCE-DATETIME>20250729092821
ACCESSION NUMBER:		0001333493-25-000083
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		17
CONFORMED PERIOD OF REPORT:	20250728
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250729
DATE AS OF CHANGE:		20250729

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			eHealth, Inc.
		CENTRAL INDEX KEY:			0001333493
		STANDARD INDUSTRIAL CLASSIFICATION:	INSURANCE AGENTS BROKERS & SERVICES [6411]
		ORGANIZATION NAME:           	02 Finance
		EIN:				770470789
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-33071
		FILM NUMBER:		251157998

	BUSINESS ADDRESS:	
		STREET 1:		13620 RANCH ROAD 620 N, SUITE A250
		CITY:			AUSTIN
		STATE:			TX
		ZIP:			78717
		BUSINESS PHONE:		737-248-2340

	MAIL ADDRESS:	
		STREET 1:		13620 RANCH ROAD 620 N, SUITE A250
		CITY:			AUSTIN
		STATE:			TX
		ZIP:			78717
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>ehth-20250728.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:7d236c73-9d17-440c-ac57-a938c861ca69,g:7140e93a-24df-4d49-b615-9630b979205b,d:789599c7446a4a33b518e0767679a780-->
<html xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns="http://www.w3.org/1999/xhtml" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>ehth-20250728</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" format="ixt:fixed-false" id="f-23">FALSE</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-24">0001333493</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="ehth-20250728.xsd"/></ix:references><ix:resources><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2025-07-28</xbrli:startDate><xbrli:endDate>2025-07-28</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i789599c7446a4a33b518e0767679a780_1"></div><div style="min-height:54pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/></tr></table></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">WASHINGTON, D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:20pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1">8-K</ix:nonNumeric></span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">CURRENT REPORT</span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Date of Report (date of earliest event reported): </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-2">July 28, 2025</ix:nonNumeric></span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:20pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-3">EHEALTH, INC.</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:120%">(Exact Name of Registrant as Specified in its Charter)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.234%"/><td style="width:0.1%"/></tr><tr style="height:0pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="f-4">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityFileNumber" id="f-5">001-33071</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityTaxIdentificationNumber" id="f-6">56-2357876</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">(State or other jurisdiction of incorporation)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">(Commission File Number)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:100%">(I.R.S. Employer Identification No.)</span></td></tr></table></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-7">13620 RANCH ROAD 620 N, SUITE A250</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:11pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-8">AUSTIN</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressStateOrProvince" id="f-9">TX</ix:nonNumeric> <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-10">78717</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">    </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:120%"> (Address of principal executive offices)&#160;&#160;&#160;&#160;(Zip Code)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="c-1" name="dei:CityAreaCode" id="f-11">737</ix:nonNumeric>) <ix:nonNumeric contextRef="c-1" name="dei:LocalPhoneNumber" id="f-12">248-2340</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:120%">(Registrant&#8217;s telephone number, including area code)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Not applicable</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:120%">(Former name or former address, if changed since last report.)</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:50.294%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:0pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr></table></div><div><span><br/></span></div><div style="padding-right:27pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</span></div><div><span><br/></span></div><div style="padding-right:27pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:174%"><ix:nonNumeric contextRef="c-1" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox" id="f-13"><ix:nonNumeric contextRef="c-1" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox" id="f-14">&#9744;</ix:nonNumeric></ix:nonNumeric> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:174%">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) </span></div><div style="padding-right:27pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:174%"><ix:nonNumeric contextRef="c-1" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox" id="f-15">&#9744;</ix:nonNumeric> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:174%">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) </span></div><div style="padding-left:18pt;padding-right:27pt;text-indent:-18pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:174%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox" id="f-16"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox" id="f-17">&#9744;</ix:nonNumeric></ix:nonNumeric> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:174%">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) </span></div><div style="padding-left:18pt;padding-right:27pt;text-indent:-18pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:174%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox" id="f-18">&#9744;</ix:nonNumeric> </span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:174%">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.852%"><tr><td style="width:1.0%"/><td style="width:35.384%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.453%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:35.387%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:Security12bTitle" id="f-19">Common Stock, par value $0.001 per share</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:TradingSymbol" id="f-20">EHTH</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-21">The Nasdaq Stock Market LLC</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:6pt"><span><br/></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter). Emerging growth company&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="f-22">&#9744;</ix:nonNumeric></span></div><div style="margin-top:6pt"><span><br/></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#168;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:0pt"><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i789599c7446a4a33b518e0767679a780_165"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.368%"><tr><td style="width:1.0%"/><td style="width:8.059%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.053%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:86.588%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Item 5.02</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:115%">Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.</span></div></td></tr></table></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">As previously disclosed on June 24, 2025, eHealth, Inc. (the &#8220;Company&#8221;) and Fran Soistman entered into a letter agreement dated as of June 18, 2025 (the &#8220;CEO Transition Letter Agreement&#8221;) pursuant to which Mr. Soistman agreed to continue serving as chief executive officer and all other roles with the Company&#8217;s subsidiaries through the earlier of (i) the effective date of the appointment of his successor as chief executive officer or (ii) September 30, 2025 (the &#8220;CEO Transition&#8221;), and following the CEO Transition, to assume the role of executive advisor until December 31, 2025 to assist with the transition to a new chief executive officer (the &#8220;Transition Period&#8221;). The Board has concluded its search for a successor chief executive officer, and on July 28, 2025, pursuant to the CEO Transition Letter Agreement, Mr. Soistman notified the Company of his decision to resign from his position as the Company&#8217;s chief executive officer and any other role other than as a member of the Company&#8217;s Board of Directors (the &#8220;Board&#8221;) effective immediately prior to the meeting of the Board to be held on September 18, 2025 at 10:00 am Eastern Time (the &#8220;CEO Resignation&#8221;). As agreed in the CEO Transition Letter Agreement, Mr. Soistman will remain with the Company as an executive advisor during the Transition Period.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On July 28, 2025, the Board appointed Derrick Duke as chief executive officer of the Company, effective immediately following the effectiveness of the CEO Resignation. Mr. Duke, age 58, will succeed Mr. Soistman as the Company&#8217;s principal executive officer. It is also expected that the Board will approve the appointment of Mr. Duke as a member of the Board. Mr. Duke will join the Company on August 4, 2025 to begin the transition process prior to the effective date of his appointment as chief executive officer of the Company. Prior to joining the Company, Mr. Duke served as chief executive officer of Magellan Health, Inc., a managed health care company, since May 2022 and was previously its chief operating and chief financial officer between January 2022 and May 2022 and chief risk officer between July 2020 and January 2022. Prior to joining Magellan Health, Mr. Duke was chief financial and chief operating officer of HealthMarkets, Inc. from 2015 to 2019. Mr. Duke holds an M.B.A. from the University of Texas at Arlington and a B.B.A. in finance from Hardin Simmons University.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Mr. Duke entered into an offer letter with Company subsidiary eHealthInsurance Services, Inc. on July 28, 2025 (the &#8220;Offer Letter&#8221;). The Offer Letter provides for (i) an annual base salary of $700,000, (ii) a target annual incentive award opportunity equal to 120% of his annual base salary, and (iii) a signing bonus of $600,000, which signing bonus is subject to repayment in the event that Mr. Duke&#8217;s employment is terminated for &#8220;cause&#8221; (as defined in the Severance Agreement described below) or by his resignation without &#8220;good reason&#8221; (as defined in the Severance Agreement) prior to the one-year anniversary of his employment start date, subject to the terms of the Sign-On Bonus Repayment Agreement affixed to the Offer Letter (the &#8220;Sign-on Bonus Agreement&#8221;). </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Subject to the approval of the compensation committee of the Board, Mr. Duke will also receive (i) a time&#8209;based award of 300,000 restricted stock units covering shares of the Company&#8217;s common stock, which award will be subject to vesting in three equal annual installments from the vesting start date (the &#8220;Initial RSU Award&#8221;) and (ii) a performance-based restricted stock unit award covering 300,000 shares of the Company&#8217;s common stock at target achievement, which award will be eligible to vest pursuant to the terms of the Company&#8217;s 2025 performance-based stock unit program, which generally provides for eligibility for vesting based on achievement of specified metrics over a three-year performance period. The vesting of each such equity award will be subject to Mr. Duke&#8217;s continued service to the Company through the applicable vesting date and each such equity award is subject to potential acceleration of vesting upon certain terminations of employment on the terms set forth in the Severance Agreement.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the Company will enter into a severance agreement with Mr. Duke (the &#8220;Severance Agreement&#8221;). Pursuant to the Severance Agreement, if Mr. Duke&#8217;s employment is terminated by the Company or its subsidiaries &#8220;without cause&#8221; or if he voluntarily resigns for &#8220;good reason&#8221; (as such terms are defined in the Severance Agreement and, in either case, a &#8220;Qualifying Termination&#8221;), Mr. Duke will be eligible to receive the following severance payments and benefits: (i) a single lump-sum cash payment in an amount equal to (A) twenty-four months of his then-current annual base salary, and (B) any earned but unpaid annual bonus with respect to the prior year based; (ii) a pro-rated target annual bonus for the year in which termination occurs, provided that if actual performance for the year exceeds target and the date of termination is July 1 or later, then additionally the remainder of his target annual bonus for such year; and (iii) Company-paid group health, dental and vision benefits for Mr. Duke and his covered dependents under the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended, for up to eighteen months, subject to certain conditions (the &#8220;COBRA Severance&#8221;); and (iv) (A) twelve months of additional vesting credit in respect of the Initial RSU Award if the Qualifying Termination is due to a termination of his employment by the Company without cause, or in respect of all outstanding equity awards subject to time-based vesting if the Qualifying Termination is due to his resignation for good reason, and (B) full vesting of performance-based equity awards for which the applicable performance metrics have been achieved but remain subject to time-based vesting. In lieu of the above, if </span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Mr. Duke experiences a Qualifying Termination during the one-year period following a change in control (as such term is defined in the Severance Agreement), then Mr. Duke will instead be eligible to receive the following severance payments and benefits: (i) a single lump-sum cash payment in an amount equal to the sum of (A) 24 months of his base salary, and (B) 200% of his then-current target annual bonus, and (c) any earned but unpaid annual bonus with respect to the prior year, (ii) the COBRA Severance, and (iii) (A) full vesting of outstanding equity awards subject to time-based vesting, and (B) full vesting of performance&#8209;based equity awards for which the applicable performance metrics have been achieved but remain subject to time-based vesting. Additionally, if Mr. Duke&#8217;s employment terminates due to his death or disability (as defined in the Severance Agreement), he (or his estate, as applicable) will be eligible to receive (i) a pro-rated target annual bonus for the year in which termination occurs based on actual achievement, and (ii) any earned but unpaid annual bonus for the prior year. The severance described in this paragraph is subject to Mr. Duke&#8217;s timely execution of a standard release of claims in favor of the Company and applicable tax withholdings.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Mr. Duke will also enter into the Company&#8217;s standard indemnification agreement for directors and officers (the &#8220;Indemnification Agreement&#8221;) which, among other things, requires the Company to indemnify Mr. Duke to the fullest extent permitted by Delaware law, including indemnification of expenses such as attorneys&#8217; fees, judgments, fines and settlement amounts incurred by Mr. Duke in any action or proceeding, including any action or proceeding by or in right of the Company, arising out of Mr. Duke services as an executive officer.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">There are no family relationships between Mr. Duke and any director or executive officer of the Company that require disclosure under Item 401(d) of Regulation S-K. Other than the Offer Letter (including the Sign-On Bonus Agreement affixed thereto), the Severance Agreement and the Indemnification Agreement, there are no transactions between Mr. Duke or any member of his immediate family, on the one hand, and the Company or any of its subsidiaries, on the other hand, that require disclosure under Item 404(a) of Regulation S-K. Furthermore, there are no arrangements or understandings between Mr. Duke and any other persons pursuant to which Mr. Duke was selected as chief executive officer of the Company.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The foregoing descriptions of the Offer Letter, Sign-On Bonus Agreement and Severance Agreement are summaries only, do not purport to be complete and are qualified in their entirety by reference to the full text of the Offer Letter (including the Sign-On Bonus Agreement affixed thereto) and the Severance Agreement, which are attached to this Current Report on Form 8-K as Exhibits 10.1 and 10.2, respectively. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div id="i789599c7446a4a33b518e0767679a780_7"></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:1.970%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:86.912%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Item 7.01</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:115%">Regulation FD Disclosure.</span></div></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On July 29, 2025, the Company issued a press release announcing the CEO Resignation and Mr. Duke&#8217;s appointment as chief executive officer, effective immediately following the effectiveness of Mr. Soistman&#8217;s resignation. A copy of such press release is attached hereto as Exhibit 99.1. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The information in Item 7.01 of this Current Report on Form 8-K and Exhibit 99.1 attached hereto is intended to be &#8220;furnished&#8221; and shall not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended. Except as shall be expressly set forth by specific reference in such filing, the information contained herein and in the accompanying Exhibit 99.1 shall not be incorporated by reference into any filing with the Securities and Exchange Commission made by the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div id="i789599c7446a4a33b518e0767679a780_10"></div><div style="-sec-extract:summary"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.368%"><tr><td style="width:1.0%"/><td style="width:8.059%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.053%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:86.588%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Item 9.01</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">&#160;Financial Statements and Exhibits.</span></td></tr></table></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;Exhibits</span></div><div style="text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:86.766%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Exhibit No.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Description</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e8eae7;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.1*</span></div></td><td colspan="3" style="background-color:#e8eae7;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex101ceoofferletter.htm">Offer Letter between eHealthInsurance Services, Inc. and Derrick Duke, dated July 28, 2025</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">10.2*</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex102ceoseveranceagreement.htm">CEO Severance Agreement between eHealth, Inc. and Derrick Duke</a></span></div></td></tr><tr><td colspan="3" style="background-color:#e8eae7;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">99.1</span></td><td colspan="3" style="background-color:#e8eae7;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex991pressreleasejuly292025.htm">Press Release of eHealth, Inc. dated July 29, 2025</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (embedded within the Inline XBRL document)</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">*     Indicates a management contract or compensatory plan or arrangement.</span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i789599c7446a4a33b518e0767679a780_13"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-top:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div style="margin-top:9pt;text-indent:18pt"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:4.325%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:45.380%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:46.995%"/><td style="width:0.1%"/></tr><tr style="height:0pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">eHealth, Inc.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Date:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">July 29, 2025</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Gavin G. Galimi</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Gavin G. Galimi</span></div><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">SVP, General Counsel and Corporate Secretary</span></div></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div><span><br/></span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>ex101ceoofferletter.htm
<DESCRIPTION>EX-10.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="i865fd979de184d6991806a11677357b4_36"></div><div style="min-height:72pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div><div><img alt="ehealthlogo1.jpg" src="ehealthlogo1.jpg" style="height:46px;margin-bottom:5pt;vertical-align:text-bottom;width:144px"></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">July 28, 2025</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Derrick Duke</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#91;*****&#93;</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#91;*****&#93;</font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dear Derrick,</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Join us in creating a better way for all, here at eHealthInsurance Services, Inc. (the &#8220;Company&#8221;)! </font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are pleased to extend to you this offer of employment to work in the position of Chief Executive Officer working in Texas remotely, subject to required business travel.  This offer is contingent upon various factors, as described below.  Please fill out the enclosed documents and return them to us as soon as possible.  </font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This position is exempt and reports directly to the Board of Directors (the &#8220;Board&#8221;) of eHealth, Inc. (&#8220;Parent&#8221; and, together with the Company, &#8220;eHealth&#8221;).  Your anticipated start date as an employee will be August 4, 2025 (the actual first day of employment being the &#8220;Start Date&#8221;) and you will assume the Chief Executive Officer position on September 18, 2025. Pending Board approval, it is also anticipated that you will be appointed to the Board of Directors when you transition to the Chief Executive Officer position.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Here are the basic terms of this offer&#58;</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Compensation and Schedule</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#58; Your initial starting salary will be at the annualized rate of $700,000.00, paid bi&#8209;weekly, less payroll deductions and other withholdings as required by applicable law. </font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Bonus Plan</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#58; You will be eligible to receive an annual discretionary performance bonus under our Employee Bonus Plan (the &#8220;Bonus Plan&#8221;) with a target incentive of 120% of your annual eligible earnings, less applicable taxes, deductions, and withholdings.  Target incentives do not constitute a promise of payment and to earn and receive a bonus you must be employed with the Company on the payment date.  Your actual bonus payment will depend on eHealth&#8217;s financial performance and assessment of your individual performance by the Board or its committee, and is subject to and governed by the terms and conditions of the Bonus Plan.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Equity Awards</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#58; At eHealth, we want you to act like an owner and, accordingly, we want you to be an owner of eHealth.  As such, we will recommend to a committee of the Board (the &#8220;Committee&#8221;) that you be granted the following awards of restricted stock units covering shares of Parent subject to service-based vesting (&#8220;RSUs&#8221;) and restricted stock units covering shares of Parent subject to performance-based vesting (&#8220;PSUs&#8221;), each under and subject to the terms of a Parent equity plan and an applicable award agreement thereunder.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">RSU Award</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#58; We will recommend to the Committee that you be granted an award of 300,000 RSUs.  The RSUs will vest annually over the course of a three-year period starting from the Vesting Commencement Date (as defined below), with one-third of the Sign-on RSUs vesting on each of the first, second, and third anniversaries of the Vesting Commencement Date, subject to your remaining a service provider through the applicable vesting date. </font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The &#8220;Vesting Commencement Date&#8221; shall occur on the 10</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> day of the applicable month of your Start Date (e.g., if your Start Date is August 4, 2025, your Vesting Commencement Date will be August 10, 2025).  The Sign-on RSUs will not be issued until the Date of Grant (as described below).  The &#8220;Date of Grant&#8221; will be in accordance with our equity grant policy as in effect from time-to-time, which currently provides that such date will occur on the later of (i) the 10th trading day after the date when the applicable committee of the Board approves the grant of your award or (ii) the 1st trading day of the month following the month in which the approval occurs. </font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">PSU Award</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#58; We will also recommend to the Committee that you be granted 300,000 PSUs subject to the terms of 2025 PSU Program.  The PSUs will vest or become eligible to vest pursuant to the terms of the 2025 PSU Program, which generally provides for eligibility to vest based on achievement of specified metrics over a three-year performance period and vesting subject to your remaining a service provider through the applicable vesting date. </font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Sign-on Bonus</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#58; You will be eligible to earn a one-time sign-on bonus in the gross amount of $600,000, less applicable taxes and withholdings (the &#8220;Sign-On Bonus&#8221;).  To receive an advance of the Sign-On Bonus, you must sign the attached Sign-On Bonus Repayment Agreement (the &#8220;Sign-On Bonus Agreement&#8221;) and return it with your signed offer letter.  If you sign such Sign&#8209;On Bonus Agreement, the Sign-On Bonus payment will be advanced to you on the first regularly scheduled payday occurring after 30 days of employment, and provided to you in a separate check.  To earn the full Sign-On Bonus, you must be continuously employed with the Company through the one-year anniversary of your Start Date, unless your employment with the Company is terminated by the Company without &#8220;Cause&#8221; or by you with &#8220;Good Reason&#8221; (as such terms are defined in the Severance Agreement (as defined below)).  In the event that your employment terminates for &#8220;Cause&#8221; or you resign your employment with the Company for any reason other than &#8220;Good Reason&#8221; prior to completing one year of service with the Company from your Start Date, you will not have earned the full Sign&#8209;On Bonus and a portion of the Sign-On Bonus advanced to you must be repaid to the Company on the terms set forth in the Sign-On Bonus Agreement.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Severance Benefits</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#58; You will be eligible to receive severance payments and benefits upon certain qualifying terminations of your employment on and subject to the terms of the Severance Agreement attached to this offer letter.  In the event of your death while you are otherwise eligible to receive payments or benefits under the Severance Agreement, the Company will use commercially reasonable efforts to accommodate execution of the Release (as defined in the Severance Agreement) by the Release Deadline (as defined in the Severance Agreement) by the person expected to be administrator of your estate in order to facilitate the holding of such payments or benefits in constructive trust until such time as formalities under applicable law are completed.  By signing this offer letter, you and the Company agree that this offer letter and the Severance Agreement constitute the entire agreement between you and the Company regarding the subject matter of this paragraph and supersede in their entirety all prior representations, understandings, undertakings or agreements (whether oral or written and whether expressed or implied).</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">  </font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Compensation Recoupment</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  All amounts payable to you pursuant to this offer letter, and otherwise, are subject to recoupment pursuant to the Company&#8217;s or Parent&#8217;s current compensation clawback or recoupment policy and any additional compensation clawback or recoupment policy or amendments to the current policy adopted by the Company or Parent or as required by law.  No recovery of compensation under such a clawback or recoupment policy will be an event giving rise to a right to resign for &#8220;Good Reason&#8221; or constitute a termination without &#8220;Cause&#8221; under the Severance Agreement, provided that such recovery is consistent with such policy.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Vacation&#47;PTO</font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#58;</font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> You will be entitled to flexible time off (&#8220;FTO&#8221;) during your </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">employment.  More </font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">information regarding our FTO policy will be provided during onboarding.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You should note that (without prejudice to the applicable provisions of the Severance Agreement) the Board may modify your compensation and the Company may modify benefits from time to time as it deems necessary.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Company Policies &#38; Procedures</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#58; As an employee of the Company, you will be expected to comply with Company policies, rules, and standards, and any changes thereto that may be adopted periodically, including without limitation, the terms of the Company&#8217;s Mutual Arbitration Agreement, Proprietary Information and Inventions Agreement, insider trading policy, code of conduct, and any other policies and programs adopted by the Company regulating the behavior of its employees, as such policies and programs may be amended.  You will be provided with this information during on-boarding.  During your employment, you will acquire knowledge regarding confidential, proprietary and&#47;or trade secret information while performing your responsibilities for the Company, which knowledge and information is and shall be the sole and exclusive property of the Company.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">At-Will Employment</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#58; The Company is an at-will employer.  That means that either you or the Company may terminate the employment relationship at any time and for any reason, with or without notice (subject to the terms of the Severance Agreement).  Nothing in this offer of employment should be construed as a guarantee of continued employment for any set period of time.  Your at-will status may not be altered in any manner by anyone, except if approved by the Board and memorialized in a written agreement signed by you and a duly authorized representative of the Board.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Offer Contingencies</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#58; This offer is contingent upon the following, and will be withdrawn (whether or not you have already signed it), if any of them are not satisfied&#58;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Signing the Company&#8217;s Mutual Arbitration Agreement, and the Proprietary Information and Inventions Agreement (see enclosed)&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Successful completion of a background investigation, consistent with applicable federal, state, and local law, including, but not limited to, a background check of employment, education history, criminal history, and credit history.  If you are allowed to start employment before the background check has been completed, successful passage of the background check will be a condition of continued employment with the Company&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Providing documentary evidence of your identity and eligibility for employment in the United States for purposes of federal immigration law.  Such documentation must be provided to us within three business days of your Start Date&#59; and</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Confirmation that you are not subject to any legal restrictions on your activities (see below).</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Outside Activities and Conflicts of Interest</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#58; eHealth encourages employees to be innovative, explore and express their passions, and to participate in activities that better themselves and their communities, but the activity should not conflict with your obligations to eHealth.  Prior to your Start Date, and during your employment with the Company, you must disclose to the Company the existence of any and all agreements relating to any prior position of employment you have held that may affect your eligibility to be employed by the Company or limit such employment.  It is the Company&#8217;s understanding that any such agreements will not prevent you from performing the duties of your position and you represent that such is the case.  During the term of your employment with the Company, you will not engage in any other employment, occupation, consulting, or other business activity directly related to the business in which eHealth is now involved or becomes involved during the term of your employment.  Similarly, you agree that you will not bring any third-party confidential information to eHealth, including that of your former employer, and that you will not in any way utilize any such information in performing your duties for eHealth.  You agree to disclose to the Company in writing and seek appropriate approval in order to participate in any other employment, occupation, consulting, side projects or outside activities, such as development of new technologies, mentorships to start-ups, the creation of books and other writings, and other employment outside of the Company (whether or not for compensation). </font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By signing this offer letter, you represent and warrant that if you are party to any agreement or subject to any policy applicable to you that would prevent or restrict you from engaging in activities competitive with </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the activities of your former employer, or from directly or indirectly soliciting any employee, client or customer to leave the employ of, or transfer its business away from, your former employer, you have complied and will comply with it, and your employment with the Company does not violate any such agreement or policy.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Acceptance</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This offer letter and the referenced agreements and policies constitute the entire agreement between you and eHealth regarding the subject matter hereof and thereof.  This offer will remain open until July 30, 2025.  To indicate your acceptance of the Company&#8217;s offer on the terms and conditions set forth in this letter, please sign and date this letter in the space provided below and return to me.</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#91;Signature page follows&#93;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</font></div></div></div><div id="i865fd979de184d6991806a11677357b4_52"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We very much look forward to having you join us here at eHealth!</font></div><div><font><br></font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Beth A. Brooke</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beth A. Brooke</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chair of the Board</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">eHealth, Inc.</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Agreed and accepted as of the date first written above&#58;</font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Derrick Duke</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derrick Duke</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</font></div></div></div><div id="i865fd979de184d6991806a11677357b4_42"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div><div style="text-align:center"><font style="color:#494949;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Attachment</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Sign-On Bonus Repayment Agreement</font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">July 28, 2025</font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dear Derrick,</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Please review this Sign-On Bonus (&#8220;Sign-On Bonus&#8221;) Repayment Agreement (&#8220;Agreement&#8221;).  This Agreement is made between eHealthInsurance Services, Inc. (the &#8220;Company&#8221;) and the undersigned individual (&#8220;you&#8221; or &#8220;your&#8221;).</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If you sign this Agreement, you are eligible to earn a Sign-On Bonus of $600,000.00, subject to applicable taxes and withholdings.  You must remain employed with the Company for one year after your Start Date (as such term is defined in your offer letter to which this Agreement is attached) in order to earn the Sign-On Bonus in full.  If your employment is terminated, either voluntarily by you without &#8220;Good Reason&#8221; or by the Company for &#8220;Cause&#8221; (as such terms are defined in that certain Severance Agreement entered or to be entered into between you and eHealth, Inc.), you will not be eligible to earn the full Sign-On Bonus, as specified below, and must repay the unearned portion of the Sign&#8209;On Bonus advanced to you. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Repayment of Sign-On Bonus</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You agree to repay the Company the unearned portion of the Sign-On Bonus advanced to you if your employment is terminated either voluntarily by you without &#8220;Good Reason,&#8221; or by the Company for &#8220;Cause&#8221; within one year of your &#8220;Start Date&#8221;. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amount of the Sign-On Bonus you have earned, and the amount of the repayment to the Company by you, shall be determined on the following scale based on the month during which your separation from the Company takes place&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Separation Taking Place During Months Below Following the Start Date</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Percent of Total Advanced Sign-On Bonus Earned</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Percent of Total Advanced Sign-On Bonus Required to be Repaid</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0-6 months</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0%</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100%</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7-9 months</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50%</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50%</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10-12 months</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">75%</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25%</font></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12+ months</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100%</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0%</font></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the avoidance of doubt, if your employment with the Company is terminated (a) within one year of your Start Date, either (i) by you with &#8220;Good Reason&#8221; or (ii) by the Company without &#8220;Cause&#8221;, or (b) after one year from your Start Date, you shall not be required to repay any portion of the Sign-On Bonus.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Authorization to Withhold</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Should your employment with the Company be voluntarily terminated by you other than for &#8220;Good Reason&#8221; or by the Company for &#8220;Cause&#8221; within one year of the Start Date, you hereby voluntarily agree to repay to the Company the percentage of the advanced Sign-On Bonus as specified in the table above.  You understand and agree that, except as otherwise provided herein, you have not earned the full Sign-On Bonus until you have completed one (1) full year (i.e., twelve (12) complete months) from the Start Date. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You and the Company agree that the law of the state in which you work (&#8220;applicable state law&#8221;) governs deductions from your final paycheck and that the state in which you work is the State of Texas.  By signing below, you hereby authorize the Company to, if applicable, deduct the applicable repayment amount of the Sign-On Bonus (if any) from any final wages that may be due to you upon termination, to the fullest extent allowed by law.  If applicable state law requires other authorization for deduction from a final paycheck, you agree that you will execute such authorization for deduction of the applicable repayment amount of the Sign-On Bonus (if any) from your final wages as otherwise required by law.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the final wages due you are insufficient to repay the entire repayment amount of the Sign-On Bonus (if any) or if applicable state law does not allow a deduction from final wages under the circumstances present at the time your employment terminates, then you agree to repay the remaining portion of the advanced Sign-On Bonus (if any) to the Company within 30 days of the date your employment terminates.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">General&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Agreement constitutes the entire agreement between the parties, and supersedes any and all prior written or oral agreements and understandings between the parties, regarding the terms of the Sign-On Bonus.  This Agreement may not be extended, changed, or amended unless mutually agreed by both parties in writing.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#91;Signature Page Follows&#93;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To agree to the terms of the Agreement, please sign and submit this Agreement to the Company with your signed offer letter to which this Agreement is attached.  No Sign-On Bonus payment will be advanced to you until this signed Agreement is received.  If you accept the terms of the Agreement, the advance payment will be paid to you on the first regularly scheduled payday after 30 days of employment, and provided to you in a separate check.  You must be employed with the Company on the date the advance payment is made in order to receive the advance payment.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sincerely,</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Beth A. Brooke</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beth A. Brooke</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chair of the Board</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">eHealth, Inc.</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I have read, understood, and agree to the terms above as of the date first set forth above.</font></div><div><font><br></font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Derrick Duke</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derrick Duke</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>ex102ceoseveranceagreement.htm
<DESCRIPTION>EX-10.2
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="i3c1c6ec8f8574cf39f81469ad37824a2_1"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font><br></font></div><div style="margin-bottom:24pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:100%">EHEALTH, INC.<br>SEVERANCE AGREEMENT</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">THIS SEVERANCE AGREEMENT</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%"> (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Agreement</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) is entered into effective as of August 4, 2025 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Effective Date</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) by and between eHealth, Inc. (together with its subsidiaries, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Company</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) and Derrick Duke (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Executive</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;).</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:27pt">At-Will Employment</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">.  Executive and the Company agree that Executive&#8217;s employment with the Company constitutes &#8220;at-will&#8221; employment.  Executive and the Company acknowledge that this employment relationship may be terminated at any time, upon written notice to the other party, with or without Cause or Good Reason (as each such term is defined in Section 4 below), at the option either of the Company or Executive.  However, as described in this Agreement, Executive may be entitled to severance benefits depending upon the circumstances of Executive&#8217;s termination of employment.  </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:27pt">Severance Benefits</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:22.02pt">Involuntary Termination Other than for Cause or Voluntary Termination for Good Reason</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">.  If (i) Executive terminates his or her employment with the Company (or any parent or subsidiary of the Company) for &#8220;Good Reason&#8221; (as defined herein), or (ii) the Company (or any parent or subsidiary of the Company) terminates Executive&#8217;s employment for other than &#8220;Cause&#8221; (as defined herein), and Executive signs and does not revoke a standard release of claims with the Company in a form substantially similar to that attached hereto as </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%"> (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Release</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) (which such form is subject to good faith modification by the Company to comply with and be fully enforceable under applicable law, or to reflect applicable legal changes, Executive&#8217;s relocation to another jurisdiction,&#160;Executive&#8217;s separation in connection with a group termination event, Executive&#8217;s agreements and compensatory arrangements then in existence, or other similar circumstances as may reasonably be considered by the Company) and on the terms set forth in Section 2(g)(v) (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Release Requirement</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), then Executive shall receive the following severance benefits from the Company&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%;padding-left:24.69pt">Severance Payment</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">.  Executive shall receive a single lump-sum cash severance payment (less applicable withholding taxes) in an amount equal to the sum of (A) twenty-four (24) months of Executive&#8217;s then current annual base salary and (B) any earned but unpaid annual bonus with respect to the prior year, based on actual performance.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%;padding-left:21.36pt">Bonus</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">.  Executive shall receive a pro-rated target annual bonus for the year in which the termination occurs, payable at the same time as the severance payment set forth above in Section 2(a)(i).  In addition, if actual performance for the year exceeds target and the date of Executive&#8217;s termination is July 1 or later, then the Company shall pay Executive the remainder of Executive&#8217;s target annual bonus for such year (less deductions and withholdings), to be paid, subject to Section 2(g), upon the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">1.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">earlier of (i) when bonuses are paid to other executives, or (ii) March 15 of the year following the year of Executive&#8217;s termination of employment.  </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%;padding-left:18.03pt">COBRA</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">.  Subject to Executive timely electing continuation coverage under Title X of the Consolidated Budget Reconciliation Act of 1985 (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">COBRA</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), Executive shall receive one-hundred percent (100%) Company-paid group health, dental and vision coverage (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Company-Paid Coverage</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;).  If such coverage included Executive&#8217;s dependents immediately prior to the termination, such dependents shall also be covered at the Company&#8217;s expense.  Company-Paid Coverage shall continue until the earlier of (i) eighteen (18) months following the date of termination, or (ii) the date upon which Executive and his or her dependents become covered under another employer&#8217;s group health, dental and vision plans that provide Executive and his or her dependents with comparable benefits and levels of coverage (such earlier date, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">COBRA Termination Date</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;).  Notwithstanding the foregoing, if the Company determines, in its sole discretion, that it cannot provide the Company-Paid Coverage without a substantial risk of violating applicable law (including, without limitation, Section 2716 of the Public Health Service Act), the Company shall in lieu thereof provide to Executive a taxable monthly payment in an amount equal to the monthly COBRA premium that Executive would be required to pay to continue Executive&#8217;s (and Executive&#8217;s dependents&#8217;, as applicable) group health, dental and vision coverage in effect on the date of Executive&#8217;s employment termination (which amount shall be based on the premium for the first month of COBRA coverage), which payments shall be made to Executive regardless of whether Executive elects COBRA continuation coverage and shall end on the COBRA Termination Date.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%;padding-left:18.69pt">Equity Award Vesting</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">.  Executive will be granted twelve (12) additional months of vesting credit, with respect to the Initial RSU Award (with such vesting being calculated as if the award had been subject to monthly vesting).  In addition, in the case of a resignation for Good Reason, Executive will be granted twelve (12) additional months of vesting credit with respect to other outstanding and unvested time-based equity awards (with such vesting being calculated as if the award had been subject to monthly vesting).  Any PSUs subject to the Initial PSU Award that have satisfied the applicable performance metrics, but for which the service-based vesting had not yet been satisfied will also vest and the remainder of the PSUs that have not satisfied the stock price goals will terminate and be cancelled for no consideration.  All other performance-based equity awards with respect to which performance goals have been achieved but which remain subject to time-based vesting will also vest and the remainder of such performance-based equity awards that have not satisfied the performance goals as of the date of termination will terminate and be cancelled for no consideration.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:21.35pt">Involuntary Termination Other than for Cause or Voluntary Termination for Good Reason During the One-Year Period Following a Change in Control</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">.  If (i) Executive terminates his or her employment with the Company (or any parent or subsidiary of the Company) for &#8220;Good Reason&#8221; (as defined herein), or (ii) the Company (or any parent or subsidiary of the Company) terminates Executive&#8217;s employment for other than &#8220;Cause&#8221; (as </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;2.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">defined herein) during the one-year period following a Change in Control, then, subject to satisfaction of the Release Requirement, Executive shall receive the following severance benefits from the Company&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%;padding-left:24.69pt">Severance Payment</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">.  Executive shall receive a single lump-sum cash severance payment (less applicable withholding taxes) equal to the sum of (A)&#160;twenty-four (24) months of Executive&#8217;s base salary, (B) two times Executive&#8217;s then-current target annual bonus and (C) any earned but unpaid annual with respect to the prior year, based on actual performance.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%;padding-left:21.36pt">COBRA</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">.  Executive shall receive the Company-Paid Coverage described in Section 2(a)(iii) above subject to and on the terms set forth in such Section.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%;padding-left:18.03pt">Equity Award Vesting.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">  One hundred percent (100%) of Executive&#8217;s then-outstanding and unvested time-based equity awards (whether stock options, stock appreciation rights, shares of restricted stock, restricted stock units or otherwise) shall become vested.  Any PSUs subject to the Initial PSU Award that have satisfied the applicable performance metrics (including in connection with the Change in Control), but for which the service-based vesting had not yet been satisfied will also vest and the remainder of the PSUs subject to the Initial PSU Award that have not satisfied the applicable performance metrics will terminate and be cancelled for no consideration.  All other performance-based equity awards with respect to which performance goals have been achieved but which remain subject to time-based vesting will also vest and the remainder of such performance-based equity awards that have not satisfied the performance goals as of the date of termination will terminate and be cancelled for no consideration.  Equity awards that vest pursuant to this Section shall otherwise remain subject to the terms and conditions of the applicable equity incentive plan and the award agreements pursuant to which the time-based equity awards were granted.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:22.7pt">Death or Disability</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">.  If Executive&#8217;s employment with the Company terminates due to Executive&#8217;s death or Disability (as defined herein), then, subject to satisfaction of the Release Requirement, Executive (or Executive&#8217;s estate, if applicable) will receive (a) a pro-rated target annual bonus for the year in which the termination occurs to the extent performance goals are actually met&#59; and (b) any other earned but unpaid annual bonus with respect to the prior year, based on actual performance, in each case to be paid, subject to Section 2(g), upon the earlier of (i) when bonuses are paid to other executives, or (ii) March 15 of the year following the year of Executive&#8217;s termination of employment. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:21.35pt">Voluntary Resignation&#59; Termination for Cause</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">.  If Executive&#8217;s employment with the Company terminates (i) voluntarily by Executive other than for Good Reason, or (ii) for Cause by the Company, then Executive shall not be entitled to receive severance or other benefits except for those (if any) as may then be established under the Company&#8217;s then existing severance and benefits plans and practices or pursuant to other written agreements with the Company.  </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;3.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">(e)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:22.7pt">Accrued Amounts</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">.  In addition to what Executive is entitled pursuant to the applicable foregoing provisions of this Section 2, upon the termination of Executive&#8217;s employment with the Company for any reason, Executive (or Executive&#8217;s estate, as applicable) shall be entitled to all Accrued Amounts.  As used herein, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Accrued Amounts</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means (i) all earned but unpaid base salary and accrued paid time off through the effective date of such termination, (ii) reimbursement of expenses incurred by Executive through the effective date of termination which are reimbursable pursuant to the Company&#8217;s reimbursement policies, and (iii) Executive&#8217;s Initial RSU Awards to the extent vested as of the effective date of such termination.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">(f)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:24.03pt">Exclusive Remedy</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">.  The provisions of this Section 2 are intended to be and are Executive&#8217;s exclusive rights to severance payments and benefits in the event of termination of service.  The parties hereto agree that nothing herein is intended to result in duplication of severance or any other benefits.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">(g)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:22.02pt">Code Section 409A</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:24.69pt">Any amount paid under this Agreement that satisfies the requirements of the &#8220;short-term deferral&#8221; rule set forth in Section 1.409A-l(b)(4) of the regulations issued under Section 409A of the Code (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Treasury Regulations</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) shall not constitute Deferred Compensation Separation Benefits for purposes of Section 2(g)(ii) below, and consequently shall be paid to Executive promptly following termination as otherwise required by this Agreement.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21.36pt">Notwithstanding anything to the contrary in this Agreement, if Executive is a &#8220;specified employee&#8221; within the meaning of Section 409A of the Code, and the final regulations and any guidance promulgated thereunder (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Section 409A</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) at the time of Executive&#8217;s separation from service (as such term is defined in Section 409A), then the cash severance benefits payable to Executive under this Agreement along with any other severance payments or separation benefits that may be considered deferred compensation under Section 409A (together, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Deferred Compensation Separation Benefits</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) that are otherwise due to Executive on or within the six (6) month period following Executive&#8217;s separation from service shall accrue during such six (6) month period and shall become payable in a lump sum payment on the date six (6) months and one (1) day following the date of Executive&#8217;s separation from service.  All subsequent payments, if any, shall be payable in accordance with the payment schedule applicable to each payment or benefit.  Notwithstanding anything herein to the contrary, if Executive dies following his or her separation from service but prior to the six (6) month anniversary of his or her date of separation from service, then any payments delayed in accordance with this Section shall be payable in a lump sum as soon as administratively practicable after the date of Executive&#8217;s death and all other Deferred Compensation Separation Benefits shall be payable in accordance with the payment schedule applicable to each payment or benefit.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:18.03pt">Any amount paid under this Agreement that qualifies as a payment made as a result of an involuntary separation from service pursuant to Section 1.409A-l(b)(9)(iii) of the Treasury Regulations that does not exceed the Section 409A Limit (as </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;4.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">defined below) shall not constitute Deferred Compensation Separation Benefits for purposes of Section 2(g)(ii) above.  For purposes of this Section 2(g), &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Section 409A Limit</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; will mean the lesser of two (2) times&#58; (i) Executive&#8217;s annualized compensation based upon the annual rate of pay paid to Executive during the Company&#8217;s taxable year preceding the Company&#8217;s taxable year of Executive&#8217;s termination of employment as determined under Treasury Regulation 1.409A-l(b)(9)(iii)(A)(l)&#59; or (ii) the maximum amount that may be taken into account under a qualified plan pursuant to Section 401(a)(17) of the Code for the year in which Executive&#8217;s employment is terminated.  No severance or other payments or benefits otherwise payable to Executive upon a termination of employment under this Agreement or otherwise will be payable until Executive has a &#8220;separation from service&#8221; as defined under Treasury Regulation Section 1.409A-1(h), without regard to any alternative definition thereunder.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:18.69pt">It is the intent of this Agreement to comply with the requirements of Section 409A so that none of the severance payments and benefits to be provided hereunder shall be subject to the additional tax imposed under Section 409A, and any ambiguities herein shall be interpreted to so comply.  The Company and Executive agree to work together in good faith to consider amendments to this Agreement and to take such reasonable actions which are necessary, appropriate or desirable to avoid imposition of any additional tax or income recognition under Section 409A prior to actual payment to Executive.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">(v)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.02pt">Notwithstanding any other provisions of this Agreement, Executive&#8217;s receipt of severance payments and benefits under Section 2(a) or Section 2(b) of this Agreement is conditioned upon Executive (or in the event of Executive&#8217;s death, the legal representative of Executive&#8217;s estate) signing and not revoking the Release and subject to the Release becoming effective within sixty (60) days following Executive&#8217;s termination of employment (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Release Period</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;)&#59; it being understood that the Company must timely pay Executive all salary, wages, bonuses, accrued vacation, commissions and any and all other benefits due to Executive in order for Executive to agree to Section 3 of the Release.  No severance will be paid or provided unless the Release becomes effective during the Release Period.  Any severance payments to which Executive is entitled under this Agreement shall be paid by the Company to Executive in cash and in full arrears on the date on which the Release becomes effective or such later date as is required to comply with Section 409A&#59; provided however, that if the Release Period straddles two calendar years, the severance payments to which Executive is entitled under this Agreement shall be paid on the latest of (A) the date on which the Release becomes effective, (B) the first business day of the calendar year following the year in which Executive terminates employment with the Company or (C) such later date as is required to comply with Section 409A.  In addition and notwithstanding any other provisions of this Agreement, Executive&#8217;s receipt of severance payments and benefits under Section 2(a) or Section 2(b) of this Agreement also is conditioned upon Executive timely resigning from all positions Executive may hold with the Company (including, but not limited to, as a member of the Board) and any of its subsidiaries or affiliated entities at such time.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;5.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">(vi)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:18.69pt">With respect to reimbursements or in-kind benefits provided to Executive hereunder (or otherwise) that are not exempt from Section 409A, the following rules shall apply&#58; (A) the amount of expenses eligible for reimbursement, or in-kind benefits provided, during any one of Executive&#8217;s taxable years shall not affect the expenses eligible for reimbursement, or in-kind benefit to be provided in any other taxable year, (B) in the case of any reimbursements of eligible expenses, reimbursement shall be made on or before the last day of Executive&#8217;s taxable year following the taxable year in which the expense was incurred and (C) the right to reimbursement or in-kind benefits shall not be subject to liquidation or exchange for another benefit.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:27pt">Golden Parachute Excise Tax Best Results</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">.  If any payment or benefit Executive would receive pursuant to this Agreement or otherwise (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Payment</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) would (i) constitute a &#8220;parachute payment&#8221; within the meaning of Section 280G of the Internal Revenue Code of 1986, as amended (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Code</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), and (ii) but for this sentence, be subject to the excise tax imposed by Section 4999 of the Code (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Excise Tax</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), then such Payment shall be reduced to the Reduced Amount.  The &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Reduced Amount</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall be either (x) the largest portion of the Payment that would result in no portion of the Payment being subject to the Excise Tax or (y) the largest portion, up to and including the total, of the Payment, whichever amount, after taking into account all applicable federal, state and local employment taxes, income taxes, and the Excise Tax (all computed at the highest applicable marginal rate), results in Executive&#8217;s receipt, on an after-tax basis, of the greater amount of the Payment notwithstanding that all or some portion of the Payment may be subject to the Excise Tax.  If a reduction in payments or benefits constituting &#8220;parachute payments&#8221; is necessary so that the Payment equals the Reduced Amount, reduction shall occur in the following order&#58; (A) cash payments shall be reduced first and in reverse chronological order such that the cash payment owed on the latest date following the occurrence of the event triggering such excise tax will be the first cash payment to be reduced&#59; (B) accelerated vesting of stock awards shall be cancelled&#47;reduced next and in the reverse order of the date of grant for such stock awards (i.e., the vesting of the most recently granted stock awards will be reduced first)&#59; and (C) employee benefits shall be reduced last and in reverse chronological order such that the benefit owed on the latest date following the occurrence of the event triggering such excise tax will be the first benefit to be reduced.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">The Company shall appoint a nationally recognized accounting firm or consulting firm to make the determinations required hereunder and perform the foregoing calculations.  The Company shall bear all expenses with respect to the determinations by such accounting or consulting firm required to be made hereunder.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">The accounting or consulting firm engaged to make the determinations hereunder shall provide its calculations, together with detailed supporting documentation, to the Company and Executive within fifteen (15) calendar days after the date on which right to a Payment is triggered (if requested at that time by the Company or Executive) or such other time as requested by the Company or Executive.  If the accounting or consulting firm determines that no Excise Tax is payable with respect to a Payment, either before or after the application of the Reduced Amount, it shall furnish the Company and Executive with an opinion reasonably acceptable to Executive that no Excise Tax will be imposed with respect to such Payment.  Any good faith </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;6.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">determinations of the accounting or consulting firm made hereunder shall be final, binding and conclusive upon the Company and Executive.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:27pt">Definition of Terms</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">.  The following terms referred to in this Agreement shall have the following meanings&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:22.02pt">Board of Directors</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">.  &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Board</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; or &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Board of Directors</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean the Board of Directors of the Company.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:21.35pt">Cause</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">.  &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Cause</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall mean (i) Executive&#8217;s commission of any act of fraud, embezzlement or dishonesty, (ii) Executive&#8217;s conviction of, or plea of </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">nolo contendere</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%"> to, a felony under the laws of the United States or any state thereof, (iii) Executive&#8217;s continued failure to perform lawfully assigned duties for thirty (30) days after receiving written notification from the Company, (iv) Executive&#8217;s unauthorized use or disclosure of confidential information or trade secrets of the Company, or (v) any other intentional misconduct by Executive that adversely affects the business of the Company in a material manner, in all cases (other than in the case of clause (ii)) after having been provided with written notice and a fourteen (14)-day opportunity to cure (if the Board determines a cure to be possible) and to be heard by the Board with Executive&#8217;s counsel present.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:22.7pt">Change in Control</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">.  &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Change in Control</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means the occurrence of any of the following, in one or a series of related transactions&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:24.69pt">Any &#8220;person&#8221; (as such term is used in Sections 13(d) and 14(d) of the Securities Exchange Act of 1934, as amended) becomes the &#8220;beneficial owner&#8221; (as defined in Rule 13d-3 under said Act), directly or indirectly, of securities of the Company representing fifty percent (50%) or more of the total voting power represented by the Company&#8217;s then outstanding voting securities&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21.36pt">The consummation of a merger or consolidation of the Company with any other corporation, other than a merger or consolidation which would result in the voting securities of the Company outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into voting securities of the surviving entity) at least fifty percent (50%) of the total voting power represented by the voting securities of the Company or such surviving entity outstanding immediately after such merger or consolidation&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:18.03pt">The consummation of the sale, lease or other disposition by the Company of all or substantially all the Company&#8217;s assets.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:21.35pt">Disability</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">.  &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Disability</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means Executive (i) is unable to engage in any substantial gainful activity by reason of any medically determinable physical or mental impairment which can be expected to result in death or can be expected to last for a continuous period of not less than twelve (12) months, or (ii) is, by reason of any medically determinable physical or mental impairment which can be expected to last for a continuous period of not less </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;7.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">than twelve (12) months, receiving income replacement benefits for a period of not less than three (3) months under an accident and health plan covering Company employees.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">(e)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:22.7pt">Good Reason</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">.  &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Good Reason</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means any of the following is undertaken by the Company (or its acquirer) without Executive&#8217;s express written consent&#58; (i) a reduction in Executive&#8217;s title, (ii) a material reduction of Executive&#8217;s duties, authority or responsibilities (including but not limited to a material reduction in duties, authority or responsibilities solely by virtue of the Company being acquired and made part of a larger entity such that Executive is no longer the Chief Executive Officer of a publicly-traded company)&#59; (iii) any material (at least ten percent (10%)) reduction of Executive&#8217;s base salary or potential target bonus (other than a proportionate reduction in Executive&#8217;s base salary or potential bonus that affects all senior management of the Company)&#59; (iv) a material change in the geographic location at which Executive must perform services&#59; provided that in no instance will the relocation of Executive to a facility or location of thirty-five (35) miles or less from Executive&#8217;s then current office location (or one of Executive&#8217;s then-current office locations, if applicable) be deemed material for purposes of this Agreement&#59; (v) failure of a successor to the Company to assume this Agreement&#59; or (vi) prior to a Change of Control (and, following a Change of Control if the Company&#8217;s Board exists following such Change of Control) Executive&#8217;s position as a member of the Board terminates as a result of the Board&#8217;s failing to nominate him for election or re-election thereto&#59; provided, however, that Good Reason shall not exist unless Executive has provided written notice to the Board of Directors of the purported grounds for the Good Reason within sixty (60) days of its initial existence and the Company has been provided at least thirty (30) days to remedy the condition&#59; and provided, further that Executive resigns his or her employment within ninety (90) days after Executive&#8217;s provision of such notice to the Board of Directors.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">(f)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:24.03pt">Initial RSU Award.  </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Initial RSU Award</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means that certain grant of Company time-based restricted stock units granted to Executive as described in the Offer Letter.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">(g)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:22.02pt">Initial PSU Award</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">.  &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Initial PSU Award</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means that certain grant of Company performance-based restricted stock units (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">PSUs</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) granted to Executive as described in the Offer Letter. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">(h)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:21.35pt">Offer Letter</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">.  &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Offer Letter</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means that certain offer letter entered into between Executive and eHealthInsurance Services, Inc.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:27pt">Successors</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:22.02pt">The Company&#8217;s Successors</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">.  Any successor to the Company (whether direct or indirect and whether by purchase, merger, consolidation, liquidation or otherwise) to all or substantially all of the Company&#8217;s business and&#47;or assets shall assume the obligations under this Agreement and agree expressly to perform the obligations under this Agreement in the same manner and to the same extent as the Company would be required to perform such obligations in the absence of a succession.  For all purposes under this Agreement, the term &#8220;Company&#8221; shall include any successor to the Company&#8217;s business and&#47;or assets which executes and delivers the assumption agreement described in this Section 5(a) or which becomes bound by the terms of this Agreement by operation of law.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;8.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:21.35pt">Executive&#8217;s Successors</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">.  The terms of this Agreement and all rights of Executive hereunder shall inure to the benefit of, and be enforceable by, Executive&#8217;s personal or legal representatives, executors, administrators, successors, heirs, distributees, devisees and legatees.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">6.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:27pt">Notice</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">.  All notices and other communications required or permitted hereunder shall be in writing, shall be effective when given, and shall in any event be deemed to be given upon receipt or, if earlier, (a) five (5) days after deposit with the U.S. Postal Service or other applicable postal service, if delivered by first class mail, postage prepaid, (b) upon delivery, if delivered by hand, (c) one (1) business day after the business day of deposit with Federal Express or similar overnight courier, freight prepaid, (d) one (1) business day after the business day of facsimile transmission, if delivered by facsimile transmission with copy by first class mail, postage prepaid, (e) upon transmission, if sent by email, and shall be addressed (i) if to Executive, at his or her last known residential address or email address and (ii) if to the Company, at the address of its principal corporate offices (attention&#58; Secretary), or in any such case at such other address as a party may designate by ten (10) days&#8217; advance written notice to the other party pursuant to the provisions above.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">7.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:27pt">Notice of Termination</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">.  Any termination by the Company for Cause or by Executive for Good Reason or as a result of a voluntary resignation shall be communicated by a notice of termination to the other party hereto given in accordance with Section 6 of this Agreement.  Such notice shall indicate the specific termination provision in this Agreement relied upon, shall set forth in reasonable detail the facts and circumstances claimed to provide a basis for termination under the provision so indicated, and shall specify the termination date (which shall be not more than thirty (30) days after the giving of such notice).  The failure by Executive to include in the notice any fact or circumstance which contributes to a showing of Good Reason shall not waive any right of Executive hereunder or preclude Executive from asserting such fact or circumstance in enforcing his or her rights hereunder.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">8.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:27pt">Miscellaneous Provisions</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:22.02pt">No Duty to Mitigate</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">.  Executive shall not be required to mitigate the amount of any payment contemplated by this Agreement, nor shall any such payment be reduced by any earnings that Executive may receive from any other source.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:21.35pt">Waiver</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">.  No provision of this Agreement shall be modified, waived or discharged unless the modification, waiver or discharge is agreed to in writing and signed by Executive and by an authorized officer of the Company (other than Executive).  No waiver by either party of any breach of, or of compliance with, any condition or provision of this Agreement by the other party shall be considered a waiver of any other condition or provision or of the same condition or provision at another time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:22.7pt">Headings</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">.  All captions and section headings used in this Agreement are for convenient reference only and do not form a part of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:21.35pt">Entire Agreement</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">.  This Agreement represents the entire agreement between Executive and the Company regarding Executive&#8217;s severance agreement with the Company, and </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;9.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">supersede in their entirety all prior representations, understandings, undertakings or agreements (whether oral or written and whether expressed or implied), of the parties with respect to the subject matter hereof.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">(e)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:22.7pt">Choice of Law</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">.  The validity, interpretation, construction and performance of this Agreement shall be governed by the laws of the State of Texas (with the exception of its conflict of laws provisions).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">(f)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:24.03pt">Severability</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">.  The invalidity or unenforceability of any provision or provisions of this Agreement shall not affect the validity or enforceability of any other provision hereof, which shall remain in full force and effect.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">(g)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:22.02pt">Withholding</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">.  All payments made pursuant to this Agreement will be subject to withholding of applicable income and employment taxes.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">(h)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:21.35pt">Counterparts</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">.  This Agreement may be executed in counterparts, each of which shall be deemed an original, but all of which together will constitute one and the same instrument.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">&#91;REMAINDER OF PAGE INTENTIONALLY LEFT BLANK&#93;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;10.</font></div></div></div><div id="i3c1c6ec8f8574cf39f81469ad37824a2_4"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">IN WITNESS WHEREOF, the parties hereto have duly executed and delivered this Agreement as of the Effective Date.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-indent:36pt"><font><br></font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:100%">COMPANY</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:100%">EHEALTH, INC.</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">By&#58; &#47;s&#47; Gavin Galimi</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">Gavin Galimi</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">SVP, General Counsel</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">By&#58; &#47;s&#47; Derrick Duke</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">Name&#58; Derrick Duke</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="padding-left:216pt"><font><br></font></div><div style="padding-left:216pt"><font><br></font></div><div style="padding-left:216pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;11.</font></div><div><font><br></font></div></div></div><div id="i3c1c6ec8f8574cf39f81469ad37824a2_7"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:24pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">EXHIBIT A<br><br>RELEASE OF CLAIMS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">THIS RELEASE OF CLAIMS</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%"> (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Agreement</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) is made by and between eHealth, Inc. (together with its subsidiaries, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Company</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) and Derrick Duke (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Executive</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">WHEREAS</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">, Executive has agreed to enter into a release of claims in favor of the Company upon certain events specified in the Severance Agreement by and between Company and Executive (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Severance Agreement</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">NOW THEREFORE</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">, in consideration of the mutual promises made herein, the Parties hereby agree as follows&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:100%">1.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:27pt">Termination</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">.  Executive&#8217;s employment from the Company terminated on ___________________________.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:100%">2.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:27pt">Confidential Information</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">.  Executive shall continue to maintain the confidentiality of all confidential and proprietary information of the Company and shall continue to comply with the terms and conditions of the Proprietary Information and Inventions Agreement between Executive and the Company (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Confidentiality Agreement</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;).  Executive&#8217;s signature below constitutes Executive&#8217;s certification under penalty of perjury that Executive has returned to the Company all Company property, Company confidential and proprietary information, login credentials used in performing services for the Company, items developed or obtained by Executive in connection with Executive&#8217;s employment with the Company, and all other items belonging to the Company.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:100%">3.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:27pt">Payment of Salary</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">.  Executive acknowledges and represents that the Company has paid all salary, wages, bonuses, accrued vacation, commissions and any and all other benefits due to Executive.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:100%">4.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:27pt">Release of Claims</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">.  Except as set forth in the last paragraph of this Section 4, Executive agrees that the foregoing consideration represents settlement in full of all outstanding obligations owed to Executive by the Company.  Executive, on behalf of himself or herself, and Executive&#8217;s respective heirs, family members, executors and assigns, hereby fully and forever releases the Company and its past, present and future officers, agents, directors, employees, investors, shareholders, administrators, affiliates, divisions, subsidiaries, parents, predecessor and successor corporations, and assigns (collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Released Parties</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), from, and agrees not to sue or otherwise institute or cause to be instituted any legal or administrative proceedings concerning, any claim, duty, obligation or cause of action relating to any matters of any kind, whether presently known or unknown, suspected or unsuspected, that Executive may possess arising from any omissions, acts or facts that have occurred up until and including the date Executive signs this Agreement including, without limitation,</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">any and all claims relating to or arising from Executive&#8217;s employment relationship with the Company and the termination of that relationship&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21.35pt">any and all claims relating to, or arising from, Executive&#8217;s right to purchase, or actual purchase of shares of stock of the Company, including, without limitation, any claims for fraud, misrepresentation, breach of fiduciary duty, breach of duty under applicable state corporate law, and securities fraud under any state or federal law&#59;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;1.</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">any and all claims for wrongful discharge of employment&#59; termination in violation of public policy&#59; discrimination&#59; breach of contract, both express and implied&#59; breach of a covenant of good faith and fair dealing, both express and implied&#59; promissory estoppel&#59; negligent or intentional infliction of emotional distress&#59; negligent or intentional misrepresentation&#59; negligent or intentional interference with contract or prospective economic advantage&#59; unfair business practices&#59; defamation&#59; libel&#59; slander&#59; negligence&#59; personal injury&#59; assault&#59; battery&#59; invasion of privacy&#59; false imprisonment&#59; and conversion&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21.35pt">any and all claims for violation of any federal, state or municipal statute, including, but not limited to, the Age Discrimination in Employment Act of 1967 (ADEA), the Civil Rights Act of 1866, Title VII of the Civil Rights Act of 1964, the Civil Rights Act of 1991, the Employee Retirement Income Security Act (ERISA), the Americans with Disabilities Act, the Family and Medical Leave Act (FMLA), the Worker Adjustment and Retraining Notification Act, the Massachusetts Fair Employment Practices Act, the Massachusetts Payment of Wages Law, the Massachusetts Overtime Law, the Massachusetts Minimum Fair Wages Law, the Massachusetts Civil Rights Act, the Massachusetts Equal Rights Act, the Massachusetts Equal Pay Act, the Massachusetts Labor and Industries Act, the Massachusetts Privacy Act, the Massachusetts Independent Contractor statute, the Massachusetts Earned Sick Time Law, the anti-discrimination provisions of the Massachusetts Paid Family and Medical Leave Act, the New Jersey Conscientious Employee Protection Act, the New Jersey Law Against Discrimination, the West Virginia Human Rights Act, the Texas Payday Act, the Texas Workers&#8217; Compensation Act, Chapter 21 of the Texas Labor Code (also known as the Texas Commission on Human Rights Act), the Minnesota Human Rights Act, any amendments to any of the foregoing, and any other federal, state, or local law, rule, ordinance, or regulation&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">any and all claims for violation of the federal, or any state, constitution&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.03pt">any and all claims arising out of any other laws and regulations relating to employment or employment discrimination&#59; and</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:100%">(g)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">any and all claims for attorneys&#8217; fees and costs.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">Executive agrees that the release set forth in this section shall be and remain in effect in all respects as a complete general release as to the matters released.  Nothing in this Agreement waives Executive&#8217;s rights to indemnification or any payments under any fiduciary or directors &#38; officers insurance policy, if any, provided by any act or agreement of the Company, state or federal law or policy of insurance.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">The release contained in this section does not apply to (a) the Company&#8217;s expense reimbursement policies, (b) any vested rights under the Company&#8217;s ERISA-covered employee benefit plans as applicable on the date this Agreement is signed, and (c) any claims that the controlling law clearly states may not be released by private agreement, which include claims for unemployment and&#47;or workers&#8217; compensation benefits.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:100%">5.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:27pt">Acknowledgment of Waiver of Claims under ADEA</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">.  Executive acknowledges that he or she is waiving and releasing any rights he or she may have under the Age Discrimination in Employment Act of 1967 (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">ADEA</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) and that this waiver and release is knowing and voluntary.  Executive and the Company agree that this waiver and release does not apply to any rights or claims that may arise under the ADEA after the date Executive signs this Agreement, and Executive acknowledges that the consideration given for this waiver and release Agreement is in addition to anything of value to which Executive was already entitled.  Executive further acknowledges that he or she has been advised by this writing that (a) he or she </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;2.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">should consult with an attorney prior to executing this Agreement, and is hereby advised to do so&#59; (b) he or she has at least twenty-one (21) days within which to consider this Agreement&#59; (c) he or she has seven (7) days following the execution of this Agreement by the parties to revoke the Agreement&#59; (d) this Agreement shall not be effective until the revocation period has expired&#59; and (e) nothing in this Agreement prevents or precludes Executive from challenging or seeking a determination in good faith of the validity of this waiver under the ADEA, nor does it impose any condition precedent, penalties or costs for doing so, unless specifically authorized by federal law.  In the event Executive signs this Agreement and returns it to the Company in less than the 21-day period identified above, Executive hereby acknowledges that Executive has knowingly and voluntarily chosen to waive the time period allotted for considering this Agreement.  Any revocation should be in writing and delivered to the Chief People Officer at the Company by the seventh day after the date that Executive signs this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:100%">6.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:27pt">Release of Unknown Claims</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">.  Executive waives all rights under California Civil Code 1542, below, which provides as follows&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;padding-right:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">A general release does not extend to claims that the creditor or releasing party does not know or suspect to exist in his or her favor at the time of executing the release, and that, if known by him or her, would have materially affected his or her settlement with the debtor or released party. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">Executive also releases and waives any rights he or she may have under any statute or common law principles of similar effect, including but not limited to Montana Code Annotated Section 28-1-1602, North Dakota Century Code Section 9-13-02, and South Dakota Codified Laws Section 20-7-11.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:100%">7.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:27pt">No Pending or Future Lawsuits</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">.  Executive represents that he or she has no lawsuits, claims, or actions pending in his or her name, or on behalf of any other person or entity, against the Company or any other person or entity referred to herein.  Executive further represents that he or she has (i) reported to the Company any and all work-related injuries or occupational disease incurred by Executive during his or her employment by the Company&#59; (ii) been properly provided any leave requested because of Executive&#8217;s or a family member&#8217;s health condition or military service and, that Executive has not been subjected to any improper treatment, conduct or actions due to a request for or taking such leave&#59; (iv) had the opportunity to provide the Company with written notice of any and all concerns regarding suspected ethical and compliance issues or violations on the part of any Released Party&#59; and (v) not raised a claim, including but not limited to, unlawful discrimination&#59; harassment&#59; sexual harassment, abuse, assault, or other criminal conduct&#59; failure to prevent an act of workplace harassment or discrimination&#59; or retaliation in a court or government agency proceeding, in an alternative dispute resolution forum, or through the Company&#8217;s internal complaint process, involving the Company or any other Released Party. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:100%">8.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:27pt">No Admission of Liability</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">.  No action taken by the Company, either previously or in connection with this Agreement shall be deemed or construed to be (a) an admission of the truth or falsity of any claims heretofore made or (b) an acknowledgment or admission by the Company of any fault or liability whatsoever to Executive or to any third party.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:100%">9.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:27pt">No Cooperation</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">.  Subject to the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Protected Activity Not Prohibited</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; section below, Executive agrees that Executive will not knowingly encourage, counsel, or assist any attorneys or their clients in the presentation or prosecution of any disputes, differences, grievances, claims, charges, or complaints by any third party against any of the Released Parties, unless under a subpoena or other court order to do so or as related directly to the ADEA waiver </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;3.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">in this Agreement.  Executive agrees both to immediately notify the Company upon receipt of any such subpoena or court order, and to furnish, within three (3) business days of its receipt, a copy of such subpoena or other court order.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:100%">10.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:21pt">Protected Activity Not Prohibited</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">.  Nothing in this Agreement (including but not limited to the acknowledgements, release of claims, the promise not to sue, the confidentiality obligations, and the return of property provision)&#58; (i) waives Executive&#8217;s right to testify in an administrative, legislative, or judicial proceeding concerning alleged criminal conduct, alleged unlawful employment practices regarding the Company, or alleged sexual harassment, on the part of the Company, or on the part of the agents or employees of the Company, when Executive has been required or requested to attend such a proceeding pursuant to a court order, subpoena, or written request from an administrative agency or the legislature&#59; (ii) shall have the purpose or effect of requiring Executive to conceal the details relating to any claim of discrimination, harassment, or retaliation, abuse, assault, or other criminal conduct&#59; (iii) limits or affects Executive&#8217;s right to challenge the validity of this Agreement under the ADEA or the OWBPA&#59; (iv) prevents Executive from communicating with, filing a charge or complaint with&#59; providing documents or information voluntarily or in response to a subpoena or other information request to&#59; or from participating in an investigation or proceeding conducted by the Equal Employment Opportunity Commission, National Labor Relations Board, the Securities and Exchange Commission, law enforcement, or any other any federal, state or local agency charged with the enforcement of any laws, or from responding to a subpoena or discovery request in court litigation or arbitration&#59; or (v) precludes Executive from exercising his or her rights under Section 7 of the NLRA or similar state law to engage in protected, concerted activity with other employees, non-employees and entities, although by signing this Agreement Executive waives the right to recover any individual relief (including any back pay, front pay, reinstatement or other legal or equitable relief) in any charge, complaint, or lawsuit or other proceeding brought by Executive or on Executive&#8217;s behalf by any third party, except for any right Executive may have to receive a payment or award from a government agency (and not the Company) for information provided to the government agency or where otherwise prohibited.  Additionally, nothing in this Agreement constitutes a waiver of any rights Executive may have under the Sarbanes-Oxley Act or Section 7 of the National Labor Relations Act.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:100%">11.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:21pt">Breach</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">.  Executive acknowledges and agrees that any material breach of this Agreement (unless such breach constitutes a legal action by Executive challenging or seeking a determination in good faith of the validity of the waiver herein under the ADEA) or of any provision of the Confidentiality Agreement shall entitle the Company immediately to recover and&#47;or cease providing the consideration that is contingent on Executive&#8217;s execution and non-revocation of this Agreement and to obtain damages, except as provided by law&#59; provided, however, that the Company shall not recover One Hundred Dollars ($100.00) of the consideration already paid, and such amount shall serve as full and complete consideration for the promises and obligations assumed by Executive under this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:100%">12.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:21pt">Costs</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">.  The Parties shall each bear their own costs, expert fees, attorneys&#8217; fees and other fees incurred in connection with this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:100%">13.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:21pt">Authority</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">.  Executive represents and warrants that he or she has the capacity to act on his or her own behalf and on behalf of all who might claim through him or her to bind them to the terms and conditions of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:100%">14.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:21pt">No Representations</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">.  Neither party has relied upon any representations or statements made by the other party hereto which are not specifically set forth in this Agreement.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;4.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:100%">15.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:21pt">Severability</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">.  In the event that any provision hereof becomes or is declared by a court of competent jurisdiction to be illegal, unenforceable or void, this Agreement shall continue in full force and effect without said provision.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:100%">16.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:21pt">Entire Agreement</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">.  This Agreement, along with the Severance Agreement, the Confidentiality Agreement, and Executive&#8217;s written equity compensation agreements with the Company, represents the entire agreement and understanding between the Company and Executive concerning the subject matter hereof and Executive&#8217;s separation from the Company.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:100%">17.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:21pt">No Oral Modification</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">.  This Agreement may only be amended in writing signed by Executive and the Chief Executive Officer of the Company.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:100%">18.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:21pt">Governing Law</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">.  This Agreement shall be governed by the laws of the same state in which Executive is or was last employed by the Company, without regard for choice of law provisions.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:100%">19.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:21pt">Effective Date</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">.  This Agreement is effective on the eighth (8th) day after it has been signed by both Parties, provided it has not been revoked by Executive prior to such date in accordance with the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Acknowledgement of Waiver of Claims under ADEA</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; section above.  Notwithstanding the foregoing, if Executive has been employed by the Company in Minnesota at any time during Executive&#8217;s employment with the Company, this Agreement is effective on the sixteenth (16</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:7.8pt;font-weight:400;line-height:100%;position:relative;top:-4.2pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">) day after it has been signed by both parties, provided it has not been revoked by Executive in accordance with the following&#58; Executive has fifteen (15) days after signing this Agreement to revoke it, which such revocation must be accomplished by a written notification to the Company&#8217;s Chief People Officer delivered to the Company (i) by certified mail return receipt requested, properly addressed to the Company&#8217;s Chief People Officer, and postmarked within the 15-day revocation period or (ii) by hand.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:100%">20.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:21pt">Counterparts</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">.  This Agreement may be executed in counterparts, and each counterpart shall have the same force and effect as an original and shall constitute an effective, binding agreement on the part of each of the undersigned.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:100%">21.</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:21pt">Voluntary Execution of Agreement</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">.  This Agreement is executed voluntarily and without any duress or undue influence on the part or behalf of the Parties hereto, with the full intent of releasing all claims.  The Parties acknowledge that&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">They have read this Agreement&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21.35pt">They have had the opportunity of being represented in the preparation, negotiation, and execution of this Agreement by legal counsel of their own choice or that they have voluntarily declined to seek such counsel&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">They understand the terms and consequences of this Agreement and of the releases it contains&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21.35pt">They are fully aware of the legal and binding effect of this Agreement.</font></div><div style="margin-bottom:10pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;5.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">IN WITNESS WHEREOF</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">, the Parties have executed this Agreement on the respective dates set forth below.</font></div><div style="padding-left:216pt"><font><br></font></div><div style="margin-bottom:12pt;margin-top:36pt;padding-left:216pt;text-indent:-216pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.021%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.021%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.188%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.370%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:100%">EHEALTH, INC.</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">Dated&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Beth A. Brooke, Chair of the Board</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:100%">Dated&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Derrick Duke</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:12pt;margin-top:36pt;padding-left:216pt;text-indent:-216pt"><font><br></font></div><div style="margin-bottom:12pt;margin-top:36pt;padding-left:216pt;text-indent:-216pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;6.</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>4
<FILENAME>ex991pressreleasejuly292025.htm
<DESCRIPTION>EX-99.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="i1b3fa6c2e9334835aeab0c5ab4b1d46f_1"></div><div style="min-height:67.5pt;width:100%"><div style="text-align:right"><img alt="ehealthlogo.jpg" src="ehealthlogo.jpg" style="height:38px;margin-bottom:5pt;vertical-align:text-bottom;width:179px"></div></div><div style="margin-bottom:8pt"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:115%">eHealth Announces CEO Succession</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Derrick Duke Appointed Chief Executive Officer After Transition Period</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Fran Soistman to Retire, Remain on eHealth Board of Directors</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">AUSTIN, Texas, July 29, 2025 &#8211; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">eHealth, Inc. (Nasdaq&#58; EHTH), a leading private online health insurance marketplace (the &#34;Company&#34;), today announced that the Company's Board of Directors has appointed Derrick Duke as its next Chief Executive Officer. Duke will join eHealth on August 4th 2025, to begin the transition process before officially stepping into the CEO role and joining the Board of Directors on September 18th, 2025. He will succeed Fran Soistman, who, as previously announced, will retire from his role as CEO while continuing to serve on the Board</font><font style="color:#1f1f1f;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Soistman will remain with the Company as an executive advisor through December 31, 2025, to assist with the transition.    </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Derrick Duke currently serves as CEO of Magellan Health, a leading national healthcare management organization and subsidiary of Centene Corporation (NYSE&#58; CNC). Previously, he held senior leadership roles at Magellan, including the dual roles of Chief Operating and Chief Financial Officer where he led the finance organization, business transformation initiatives, and behavioral health clinical services.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;We are thrilled to welcome Derrick Duke as eHealth&#8217;s next CEO. He brings a rare combination of financial acumen, operational expertise, and deep knowledge of the healthcare and insurance landscape &#8211; exactly what&#8217;s needed to lead eHealth into its next phase of profitable growth,&#8221; said Beth Brooke, Chair of eHealth&#8217;s Board of Directors. &#8220;At Magellan, Derrick&#8217;s leadership during a key transitional period helped streamline operations, drive efficiency, and position the company for long-term growth. The Board is confident that under his seasoned leadership, eHealth will continue to innovate and deliver exceptional value to our customers, stockholders, and stakeholders alike.&#8221;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;I am honored to join eHealth at such a pivotal time in its journey. The company&#8217;s proud legacy of helping millions of consumers navigate complex healthcare decisions is inspiring, and its modern, technology-driven approach to empowering consumers with the tools to make informed decisions resonates deeply with me. I&#8217;m excited to build on that foundation and work alongside eHealth&#8217;s talented leadership team to drive even greater value to our customers,&#8221; commented Derrick Duke. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;Leading eHealth has been a privilege, and I am incredibly proud of what we have accomplished together. I want to thank our employees, partners, and customers for their trust and commitment. I am confident that under Derrick&#8217;s leadership, eHealth will continue to grow and evolve as a leader in helping individuals, families, and businesses find the right health coverage for their needs,&#8221; commented Fran Soistman.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Beth Brooke continued, &#8220;On behalf of the entire eHealth Board and Company, I want to express our deepest gratitude to Fran for his outstanding leadership and contributions to eHealth. His vision and dedication have been instrumental in successfully transforming our business operations, evidenced in the Company&#8217;s incredibly strong 2024 Annual Enrollment Period. The foundation that Fran has created in his transformational leadership will allow Derrick to take eHealth to even greater heights. Although Fran is retiring, we are thrilled that he will remain on our eHealth Board.&#34;</font></div><div><font><br></font></div><div style="height:67.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.5pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">About Derrick Duke</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Derrick Duke brings over 30 years of strategic leadership and financial expertise in the health insurance and managed care sectors. Most recently, he served as Chief Executive Officer at Magellan Health, a leading national healthcare management firm, where he led strategic growth and operational execution following a rapid rise through the C-suite &#8211; first as Chief Risk Officer in 2020, and then as Chief Operating and Financial Officer in early 2022.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Before joining Magellan, Derrick spent nearly 16 years at HealthMarkets, one of the largest U.S. health insurance agencies, holding multiple senior roles including Chief Investment Officer, Chief Financial Officer, and Chief Operating Officer. He steered the company&#8217;s finance, actuarial, IT, underwriting, compliance and customer service teams and helped lead the organization through its acquisition by UnitedHealth Group in 2019.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Earlier in his career, Derrick was Executive Vice President and Chief Investment Officer at National Health Insurance (now part of Allstate Insurance), where he gained deep experience in investment strategy and insurer financial management.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Derrick holds a bachelor&#8217;s degree in finance from Hardin-Simmons University and an MBA from the University of Texas at Arlington.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">About eHealth, Inc.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We&#8217;re Matchmakers. For over 25 years, eHealth has helped millions of Americans find the healthcare coverage that fits their needs at a price they can afford. As a leading independent licensed insurance agency and advisor, eHealth offers access to over 180 health insurers, including national and regional companies.  </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">For more information, visit </font><font style="color:#0563c1;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ehealth.com</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> or follow us on </font><font style="color:#0563c1;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">LinkedIn</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#0563c1;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Facebook</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#0563c1;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Instagram</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, and</font><font style="color:#0563c1;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> X</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Open positions can be found on our </font><font style="color:#0563c1;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">career page</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Forward Looking Statements</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">This press release contains certain forward-looking statements that are inherently subject to various risks and uncertainties that could cause actual results to differ materially from the statements made, including the date the incoming CEO is expected to join us as an employee, the expected date of the CEO transition, and our expectations regarding our business, industry and market trends, including market opportunity, consumer demand and our competitive advantage. The risks and uncertainties that could cause our results to differ materially from those expressed or implied by such forward-looking statements include those described in eHealth's most recent Annual Report on Form 10-K and Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission and available on the investor relations page of eHealth's website at http&#58;&#47;&#47;www.ehealthinsurance.com and on the Securities and Exchange Commission's website at www.sec.gov.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">All forward-looking statements in this press release are based on information available to eHealth as of the date hereof, and eHealth does not assume any obligation to update the forward-looking statements provided to reflect events that occur or circumstances that exist after the date on which they were made, except as required by law.</font></div><div><font><br></font></div><div style="height:67.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.5pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Contact&#58;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Media</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Lara Sasken </font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Chief Communications Officer </font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">pr&#64;ehealth.com</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Investors  </font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Kate Sidorovich, CFA</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Senior Vice President, Investor Relations &#38; Corporate Development </font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">investors&#64;ehealth.com</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">  </font></div><div><font><br></font></div><div style="height:67.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>ehth-20250728.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:7d236c73-9d17-440c-ac57-a938c861ca69,g:7140e93a-24df-4d49-b615-9630b979205b-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ehth="http://www.ehealthinsurance.com/20250728" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.ehealthinsurance.com/20250728">
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2025" schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ehth-20250728_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ehth-20250728_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://www.ehealthinsurance.com/role/CoverPage">
        <link:definition>0000001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>6
<FILENAME>ehth-20250728_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:7d236c73-9d17-440c-ac57-a938c861ca69,g:7140e93a-24df-4d49-b615-9630b979205b-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_SolicitingMaterial_9c3fdb31-b616-431c-966d-f0d8422fd18e_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_6a4bcbe5-723c-4895-84f3-e1553e6d9738_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_65832187-ddea-4fce-a885-b4def9492868_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_f570d8e4-98cd-40f0-837b-64623fd0bded_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_cc958dac-5d9b-482a-b0d1-96d810904439_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_c7542de6-f2d5-4d5f-a09d-82d4287556aa_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_9c231007-5a22-4df7-b490-8c93e73f4c4a_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_df81cd88-c1e0-49a8-b9fd-123770cc3458_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_0cf63360-ae7a-4785-ae7a-e0316761641b_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_585e8ea7-8411-44ce-ac4e-85eeda9c8933_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_ab026917-a58c-4f68-b7fd-404e7d0a6ea6_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_007577de-a770-494b-97f9-1e19c6661a1b_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_ff3cb8d6-cd86-468e-84dc-7a176362e0fe_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_c7ad873b-b5c5-46ef-acc6-e71e6e827496_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_1828d427-a790-42f4-b9db-d2b9f9065998_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_e80cff9e-ec55-4d76-9e63-b2bdf1925e66_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_ce646524-afb9-4f5c-bad7-bc5114bdb8cf_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_e3d6af6f-f05f-40fe-bd90-c970da060731_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_ccfadaf3-3bc8-4551-aad8-22c550f0dd7d_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_e20b1cac-7ec6-4381-8664-fc8eac9dbe6f_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_2889a730-8f7e-4eb0-8817-fc5b73c691bf_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_557734bf-d1a9-462d-89cb-ddf5adaca6ff_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>7
<FILENAME>ehth-20250728_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:7d236c73-9d17-440c-ac57-a938c861ca69,g:7140e93a-24df-4d49-b615-9630b979205b-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/CoverPage" xlink:type="simple" xlink:href="ehth-20250728.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://www.ehealthinsurance.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_0d08806e-87ac-4132-8732-637bdd9e11dd" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_2993c1e0-6c0f-4227-8962-4e8a6e82377d" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0d08806e-87ac-4132-8732-637bdd9e11dd" xlink:to="loc_dei_DocumentType_2993c1e0-6c0f-4227-8962-4e8a6e82377d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_3d4c2aad-172f-4ab1-acea-e97cb6c460a2" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0d08806e-87ac-4132-8732-637bdd9e11dd" xlink:to="loc_dei_DocumentPeriodEndDate_3d4c2aad-172f-4ab1-acea-e97cb6c460a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_3cf6fbcd-d7ec-44ef-93e7-1e06a36746ca" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0d08806e-87ac-4132-8732-637bdd9e11dd" xlink:to="loc_dei_EntityRegistrantName_3cf6fbcd-d7ec-44ef-93e7-1e06a36746ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_fd2902d6-018a-41cc-9f94-3d9b73ac9849" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0d08806e-87ac-4132-8732-637bdd9e11dd" xlink:to="loc_dei_EntityIncorporationStateCountryCode_fd2902d6-018a-41cc-9f94-3d9b73ac9849" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_a6a66a72-f92e-4ac5-82be-b8422fe7fd64" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0d08806e-87ac-4132-8732-637bdd9e11dd" xlink:to="loc_dei_EntityFileNumber_a6a66a72-f92e-4ac5-82be-b8422fe7fd64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_1f8a6c4d-77e9-47be-8699-97b0eea28c03" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0d08806e-87ac-4132-8732-637bdd9e11dd" xlink:to="loc_dei_EntityTaxIdentificationNumber_1f8a6c4d-77e9-47be-8699-97b0eea28c03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_1acd5921-cd16-4c8e-8804-ae45f50be7c8" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0d08806e-87ac-4132-8732-637bdd9e11dd" xlink:to="loc_dei_EntityAddressAddressLine1_1acd5921-cd16-4c8e-8804-ae45f50be7c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_5715a8af-f64a-478a-a498-be16e0a1061b" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0d08806e-87ac-4132-8732-637bdd9e11dd" xlink:to="loc_dei_EntityAddressCityOrTown_5715a8af-f64a-478a-a498-be16e0a1061b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_bba97693-70b2-4012-9b29-c064fabd743a" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0d08806e-87ac-4132-8732-637bdd9e11dd" xlink:to="loc_dei_EntityAddressStateOrProvince_bba97693-70b2-4012-9b29-c064fabd743a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_b316be7b-ec86-4562-b080-21d2e9f35baa" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0d08806e-87ac-4132-8732-637bdd9e11dd" xlink:to="loc_dei_EntityAddressPostalZipCode_b316be7b-ec86-4562-b080-21d2e9f35baa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_b0d7998f-9835-4c65-a721-65c63bbbb515" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0d08806e-87ac-4132-8732-637bdd9e11dd" xlink:to="loc_dei_CityAreaCode_b0d7998f-9835-4c65-a721-65c63bbbb515" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_537f866d-8102-49af-bf81-1d783a878589" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0d08806e-87ac-4132-8732-637bdd9e11dd" xlink:to="loc_dei_LocalPhoneNumber_537f866d-8102-49af-bf81-1d783a878589" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_23c5eb4e-5fde-4329-95d0-cbb1baee5f88" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0d08806e-87ac-4132-8732-637bdd9e11dd" xlink:to="loc_dei_WrittenCommunications_23c5eb4e-5fde-4329-95d0-cbb1baee5f88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_2a7840bc-a092-4c8f-a50e-b90a903a2cda" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0d08806e-87ac-4132-8732-637bdd9e11dd" xlink:to="loc_dei_SolicitingMaterial_2a7840bc-a092-4c8f-a50e-b90a903a2cda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_2e852ba5-9ebd-4acd-b922-950caee2bfcc" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0d08806e-87ac-4132-8732-637bdd9e11dd" xlink:to="loc_dei_PreCommencementTenderOffer_2e852ba5-9ebd-4acd-b922-950caee2bfcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_8770c9bf-be6a-40d4-9ba7-b3650f26c4c9" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0d08806e-87ac-4132-8732-637bdd9e11dd" xlink:to="loc_dei_Security12bTitle_8770c9bf-be6a-40d4-9ba7-b3650f26c4c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_7dd4ce96-c1e6-4e00-b48b-695568c5135e" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0d08806e-87ac-4132-8732-637bdd9e11dd" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_7dd4ce96-c1e6-4e00-b48b-695568c5135e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_2fef333c-7e50-4fac-99fb-ec6229cc7faf" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0d08806e-87ac-4132-8732-637bdd9e11dd" xlink:to="loc_dei_TradingSymbol_2fef333c-7e50-4fac-99fb-ec6229cc7faf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_388eddc4-fb5f-492c-a6f3-a7763f0163ec" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0d08806e-87ac-4132-8732-637bdd9e11dd" xlink:to="loc_dei_SecurityExchangeName_388eddc4-fb5f-492c-a6f3-a7763f0163ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_14825924-8a9e-409b-89ab-6c69d2a68215" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0d08806e-87ac-4132-8732-637bdd9e11dd" xlink:to="loc_dei_EntityEmergingGrowthCompany_14825924-8a9e-409b-89ab-6c69d2a68215" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_30a3da17-1cbe-4dc2-90d6-a02a67c72eb8" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0d08806e-87ac-4132-8732-637bdd9e11dd" xlink:to="loc_dei_AmendmentFlag_30a3da17-1cbe-4dc2-90d6-a02a67c72eb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_5d586f92-c22e-4dd0-868b-28b1861caadf" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0d08806e-87ac-4132-8732-637bdd9e11dd" xlink:to="loc_dei_EntityCentralIndexKey_5d586f92-c22e-4dd0-868b-28b1861caadf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>ehealthlogo.jpg
<TEXT>
begin 644 ehealthlogo.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" )X"N0# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M/K5'^9!_:6$_Y^(^K.:.:^4_^'D/PK_Y]=?_ /  ?_%T?\/(?A7_ ,^NO_\
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MY -+6IL%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 - S7Y>?\ !1=,?M 0(&;#:1!SGIN>0''_ 'P/S-?J&M?E]_P4
M8_Y.$M/^P/;?^C)Z\W,?X!\WG_\ NA\N#=@?,:,M_>-%%?)V/S(,M_>-&6_O
M&BB@89;^\:,M_>-%% !EO[QI,$<J[J?9C2T4#NQ]G<7&FW27-E=365PK;O-M
MG\MB?4E<9KZ;^"/[=OC'X;75GIWB>5_$OA_Y4W3+NNH% P K@C@#^\"?>OF&
MDP1RK%&[LO4^U;1JSA\+.O#XRMA9\U.3L?MK\+?BMX>^+GA6VUSP]?)>6T@
M=01OA?'*..Q%=?EO2OQ>^!OQNUWX#^-(-:TAY!ITLJK?Z=N)AG0GEBN?O>^:
M_7KX<_$+2OB=X.T[Q%HTWFV=[$K@9^:-L<HWN#P:^GPF*6(C9[GZ/EN90QU/
M722.I'3FEI!T%+7HGNA1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110!^0'[9Y9?VF?'@5V7]];KD'TMU?\ F?RK
MQDLS')8Y/->S?MH?\G.>._\ KXA_](UKQBOBJRM4D?CN._WFHO,,M_>-&6_O
M&BBN8X0RW]XT9;^\:** #+?WC1EO[QHHH .5Y4LI]0QJ;3[RYTFZ2ZL;F:QN
ME;<)[61HGSZY4C-0T4TW'8I2E'9GU/\  S]OKQAX NK/2?%K/XD\/C"?:9ES
M=0J!@8;(W #^\"?>OT1^&_Q-T#XK>%[;7?#E\E[9S  X^]&W=7'8BOQ'QSN/
M+@\/W ]/I7J'P"^/NN? 3QE%J-A<.^D7,BI?V,F6A=">6"@C##L<_A7KX;'S
MC-0J.Z/J,OSRI0FJ>(=X]S]E :-QKGO ?C;2OB-X3TW7]&N5NK&^A6:-E/(R
M,[6'9AT(KH1\P!'(KZ7XE='Z'"4:D5*+T8ZBBBF6%%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M#(,&OJJ&(C65T?IN!QD,924X[]1XZ4M(.E+72>@%%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** &K7Y??\ !1C_ ).$M/\ L#VW
M_HR>OU!6OR^_X*,?\G"6G_8'MO\ T9/7FYC_  /FCYO/_P#=/F?+E%%%?*'Y
MF%%%% !1110 4444 %%%% +38-HR".#ZBOL+_@G3\9)/#OC&[\!WUR3INK9E
ML%DR2MPO+@'H >>WI7Q[6WX%\33^#?&N@:Y92&"ZTZ^2Y5NW!4$'V()S750J
M.G5C)'?@<0\/B(S3ZG[E*<J#2U7L+I+VQ@N(VW1RHKJWJ",BK%?9+57/V"+N
MDPHHHIC"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** /R _;0_Y.<\=_]?$/_I&M>,5[/^VA_P G.>._^OB'_P!(UKQB
MOBZ_\61^/8[_ 'FIZA1117,< 4444 %%%% !1110 4+\ON.X/0T44!LK'VC_
M ,$Y?C!-IGB2^^'U_=@6E]&]WI\;?P2*?F4'/ *\X]0*_1)#\O' [8K\1?A;
MXL?P'\2O#6OH_EFPOXIW?_IED*R_K7[<PN)(T<<AAD5]3@*KJ4]7L?I.08AU
M<.X2=W$DHHHKU#Z<**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 -6OR^_P""C'_)PEI_V![;_P!&3U^H*U^7W_!1C_DX2T_[
M ]M_Z,GKS<Q_@?-'S>?_ .Z?,^7****^4/S,**** "BBB@ HHHH **** "FL
MHF5E/R[L+E>H^8<C\J=21_>7_>'_ *%3@..Z/V\^$]T]]\+?!]S+CS)M'LY&
MQTR84)_G75UQWP;_ .21>"/^P)9?^B$KL:^YA\*/VJE_#CZ(****LU"BBB@
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M_!/?_DXJV_[!T_\ 6NK"_P >)Z66_P"]4O4_5!?NBEI%^Z/I2U]F?KP4444
M%%%% !1110 4444 %%%% !1110 4444 >%?MK_\ )L_CC_KT7_T8M?D@_P!Y
MOK7ZW_MK_P#)L_CC_KT7_P!&+7Y(/]YOK7SF9?QH^A^><1?[Q'T&T445XI\D
M%%%% !1110 4444 %%%% 'U'_P $YI&'[0%RH)"G1I20._[SO7Z@XK\O/^"<
M_P#R<%<?]@67_P!&5^HGI7U.6_P#],R'_<UZBT445ZA](%%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M+2+TI:^@6Q]R%%%%, HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH ;V-?D;^W)_P G2>-OK8_^D"5^N78U^1O[<G_)TGC;ZV/_ *0)
M7DYE_!^9\OQ#_NJ]3PVBBBOF#\W"BBB@ HHHH **** "BBB@ K]H_P!GO_D@
M_P ._P#L7=/_ /2:.OQ<K]H_V>_^2#_#O_L7=/\ _2:.O<RSXY'V/#G\2?HC
MT.BBBOH3[\**** "BBB@ HHHH **** $/>O'_P!K;_DW3QW_ -@\_P#H0KV
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M(4444P"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M2EI%^Z/I2U]F?KH4444 %%%% !1110 4444 %%%% !1110 4444 >%?MK_\
M)L_CC_KT7_T8M?D@_P!YOK7ZW_MK_P#)L_CC_KT7_P!&+7Y(/]YOK7SF9?QH
M^A^><1?[Q'T&T445XI\D%%%% !1110 4444 %%%% 'U#_P $Y_\ DX*X_P"P
M++_Z,K]1/2OR[_X)S_\ )P5Q_P!@67_T97ZB>E?49;_ /TS(?]S7J+1117JG
MT@4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 -6OR^
M_P""C'_)PEI_V![;_P!&3U^H*U^7W_!1C_DX2T_[ ]M_Z,GKS<Q_@?-'S>?_
M .Z?,^7****^4/S,**** "BBB@ HHHH **** "DC^\O^\/\ T*EI(_O+_O#_
M -"H@5'='[;?!O\ Y)%X(_[ EE_Z(2NQKCO@W_R2+P1_V!++_P!$)78U]U#X
M4?M-'^''T044459J%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 ?D!^VA_R<YX[_P"OB'_TC6O&*]G_ &T/^3G/'?\
MU\0_^D:UXQ7Q=?\ BR/Q['?[S4]0HHHKF. **** "BBB@ HHHH **** !>_^
M^O\ -:_</X>_\B'X=_[!UO\ ^BEK\/%[_P"^O\UK]P_A[_R(?AW_ +!UO_Z*
M6O<RO>9]OPW\50Z)>E+2+TI:^@6Q]R%%%%, HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH ;V-?D;^W)_R=)XV^MC_ .D"5^N78U^1
MO[<G_)TGC;ZV/_I E>3F7\'YGR_$/^ZKU/#:***^8/S<**** "BBB@ HHHH
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M /)P5Q_V!9?_ $97ZB>E?49;_ /TS(?]S7J+1117JGT@4444 %%%% !1110
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MC]IH_P ./H@HHHJS4**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH _(#]M#_ ).<\=_]?$/_ *1K7C%>S_MH?\G.>._^
MOB'_ -(UKQBOBZ_\61^/8[_>:GJ%%%%<QP!1110 4444 %%%% !1110 +W_W
MU_FM?N'\/?\ D0_#O_8.M_\ T4M?AXO?_?7^:U^X?P]_Y$/P[_V#K?\ ]%+7
MN97O,^WX;^*H=$O2EI%Z4M?0+8^Y"BBBF 4444 %%%% !1110 4444 %%%%
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MO83E?]+<\=N>,_E7Q8K.K$B20?\  C2'+$DLQ)_VC4?7J_<Q_MK&?SGVF/\
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MJ^GWUOJ=G!=VLR7%M.@DBFC.5=2,@@]QBI\G: >3WKV3Z_?86EI*6@84444
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M_'B>GEW^]4_4_5!?NCZ4M(OW1]*6OLS]="BBB@ HHHH **** "BBB@ HHHH
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MU1M*-I(*_P# C@4Y)E<<$'UVG(IE*SV'TM)2TP"BBB@ HHHH **** "BBB@
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M]]EW%KC:GC%\S[/!<3.'N8M?,^ZU9F7)XI5+=\5Y5\._C_HOC 1VMXRZ9J1
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MJ%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M.D\;?6Q_]($KR<R_@_,^7XA_W5>IX;1117S!^;A1110 4444 %%%% !1110
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M/T1Z'1117T)]^%%%% #?6OSH_P""G.%\=^#LA7VV$\@W*#@[L5^C'K7YS_\
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M)F"+A.FWV_G2JH50!P!P*^<K8N=;R/@<;F>(Q;M)VB-\L8P.!C&!2JH50HZ
M8I:*XO4\7R"BBBG=@%%%%( HHHH **** "BBB@ HHHI %-:-7'S#<<Y!R1C\
MJ=13 GL[ZYTV]BO+.>2TNH_N2P,48'UX[U]2_ W]OSQ;X!^RZ3XMB;Q-HR )
MY[@+>0H!@$'HXP!U&3ZU\ITAC7;C&#G.[O\ G6T*U2G\#L=N'Q=?"SYJ;T/V
MH^$_QN\(_&30TU'PQJT5\N!YL!^2:%NZNAY!'0^]=]FOPQ\)>+=9\"ZY!K&@
M:E<:7J$+[_-MW*[C_M#H:_0']FW]OK3?&36?A[QZ8=&U<[8(=4*E(+MQ@8()
M.&/// R>@%?0X7'1JKEGHS[S+\ZIXCW*NDC[-)]*3)Q4-O<)<1K(CJR,,JRG
M((['/>IQR*]8^E34M4P%+1104%%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444E
M #=Q[>M<9\2?BAIOPYTIKBZE5[EA^ZMUY9C]/2JWQ4^*FF_#C1GDF<27T@(A
MMUY)/J1Z5\:^)_%%_P",-6EU'4IO.GD9F7&=L8)SM4$G ';K7QF>Y['+H.G1
M=YO\#Y7-\YC@8NG3=YO\"YXX\>:GX_U9KW4IV:+<6AM>D<8)R,#U'UKG&57;
M<W+==WOZT[/J<GUHR*_'*U:IB).I5=VS\JJUJE:;G4=V)GU.3ZFER*,BC(K$
MY[+<,BC(HR*,BF4&11D49%&10 9%&11D49% !D49%&11D4 &11D49%&10 9%
M&11D49% !D49%&11D4 &11D49%&10 9%&11D49% !D49%&11D4 &11D49%&1
M0 9%&11D49% !D49%&11D4G[VXANU=N#SSGFI;2ZET^[CN;:9[>>-@Z21G!4
MBF9%&150DZ;YHZ,N,G!\T79GU3\%_CY%XB\C1]>=(-2VA8[C&U)N,<Y/WO7M
M]*]RW[AP17YR1-Y,JR*2&0[DY/RMZCWKZ4^!/QT^UB+P_P"(IS]I0*MO>2$
M2#  4G^]7ZGD'$3K6PV*?O=&?I&2Y[[6V'Q3][HSZ)7E1FEIHD7:&S\II17Z
M.?=BT444 %%%% !1110 4444 %%%% #5K\OO^"C'_)PEI_V![;_T9/7Z@K7Y
M??\ !1C_ ).$M/\ L#VW_HR>O-S'^!\T?-Y__NGS/ERBBBOE#\S"BBB@ HHH
MH **** "BBB@ I(_O+_O#_T*EI(_O+_O#_T*B!4=T?MM\&_^21>"/^P)9?\
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MUI*^;;<GS,_/93E4?-)W84444B=PHHHH$%%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 44447$TF)MRP;)R.*W?!/C36?ASX
MDM->\/7TFFZG;L#YL;'$JC^!P>"OY5AT52DXOF6YI&4H/FB[,_5S]EG]KG1_
MCOIJZ5J#1Z7XQM8E^T69^5;C &98@3]TG)VY) -?1&3^%?A/H^KWOA[5['5-
M,NI;#4+*7S8+B!MKHV<]??TK].?V1/VNK/XQZ3#X=\1S16/C.U0(4;Y1>H
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MS\IRG+FD]0&>YR?4T444KD!1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% ;!1P2&8;W7[K-U7Z>E%%'6X[M;'TY^R[^VAK'PEN+;0?%$LVK^
M$Y)!%',Y+RV(' P<_< ]0>G6OTR\+>*]*\9Z'::QHU[#J&GW4:R13PMN4J0"
M/H>>E?AB1\VY3L)&&V_Q#WKVK]F;]I;7/V?O$04+)J'A.9A]MTW<3Y8/_+2+
M)X([]:]K"X]Q]RIJCZK*LWE0E['$/3N?KWGI2;N<5S/P_P#B!HOQ,\+V6O:!
M?1WVGW2!D=.JG )5AV89Y%=)UZ]:^AC)27,F?H49*<5*#NA]+2"EJBPHHHH
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MHK#8E^^MO,_3\ASAXB*PV(?OK;S/612TB_='&*6OOC[<**** "BBB@ HHHH
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M:'_)SGCO_KXA_P#2-:\8KXNO_%D?CV._WFIZA1117,< 4444 %%%% !1110
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MMS/(Q)E<DDDGZDU6)+$D]:3@< ;1V [45\NVY:L_.93E-\TGJ%%%%! 4444
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M_,^7XA_W5>IX;1117S!^;A1110 4444 %%%% !1110 5^T?[/?\ R0?X=_\
M8NZ?_P"DT=?BY7[1_L]_\D'^'?\ V+NG_P#I-'7N99\<C['AS^)/T1Z'1117
MT)]^%%%% ">M?G/_ ,%//^1\\(?]@R?_ -#K]&/6OSG_ ."GG_(^>$/^P9/_
M .AUYV-_@L\#//\ <I'QFWWC24K?>-)7R1^6K8****8PHHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KZQ_X)L7<D?Q
MHUZ)6Q&^@NY7W%P #7R=7U7_ ,$W/^2W:W_V+\G_ *4BNK!:5XM'KY7IC::1
M^G0I:1>E+7V9^LA1110!X5^VO_R;/XX_Z]%_]&+7Y(/]YOK7ZW_MK_\ )L_C
MC_KT7_T8M?D@_P!YOK7SF9?QH^A^><1?[Q'T&T445XI\D%%%% !1110 4444
M %%%% !CYB<\XQ0. !UHHI6Z@%%%%, HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "AE#%#C!0Y7!Z444=+ >U?LQ?M*ZK\!
M?%BH7>\\+W4BB_T_G$>3_K8^>&[GK7ZQ>$?%FF>-_#MAK>CW4=YI]["LT,J'
MJK $9]#STK\,6C#! >2A+*>XS7U#^Q7^TU<?"7Q9;^%]?N6?PMJTFR&20Y%O
M,3U'/ ]J]? XKD?LI['UV3YI[*7L*KT9^HPI:@MKJ&XMXY89%DB9 ZNIR&4C
M@@]Q4]?3'Z"O(****!A1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 )GK4%Q>):PO)*P5%!8D]@.]3$\U
MX!^TG\4#I.GCPYILXCOKM?W[K]Y8_0'/&:\S,,;# 8>5:?38X<;BX8.BZLSR
MOXX_%*7XA>()K2TF_P")+8MMC7D><X.,]>1Z5YNS'<=Q^;/-1JJ[4 ^ZO04_
M=ZG-?@&,QD\=6=6?4_%<9BI8JJZDG=L,BC(HR*,BN4X@R*,BC(HR*8!D49%&
M11D4 &11D49%&10 9%&11D49% !D49%&12*X#?,/EZ!LX%0N:6P1O+9"Y%&1
M5K2=)OM>NA;:=;27UP6V[8$+#\Z]9\*_LQ^(]9"RZI/#I$! .TCS)/RSP:]3
M"Y?BL8^6C!L]'#Y?BL2^6E#[SQHL5]<?[N/ZT>8&^Z,G_9RWZ"OKSP]^S%X3
MTM$:\6;59-HW?:6&PGN0 !@>V37?Z3\/_#V@QJMCI%K!M  *QC/'N:^KP_"&
M*G_&FD?2T.%<1/\ C32/A6S\/:MJ 7[)I=]=9&1Y5NQS6I!\-_%=PN4\-ZHO
M^];$5]Y1VL47"Q@#V %2^6O91^5>U3X.H1^.HSTX\*T>M1GP4_PS\7*/^1<U
M _\ ;$U2N/!?B"SS]HT2_BQU_P!':OT"\M?0?E4;0QG.5W#T(JI\'X>7PU&5
M+A;#_P#/QGYVS6\ENQ65)(64X(DC*X]JB7<V<#<.QZ?_ *Z_0J\\.:9J*E;F
MQ@F!_P">D:G^E<7KW[/O@KQ S/-I*0S,<B:!BK+].WZ5Y5;@VM'^#43]3@K<
M*U/^74SXJ^O6C(KZ&\5?LHRQ[Y-!U7> 21#>+DX[ ,,?RKQWQ5\.?$?@UB=3
MTN6.') FA_>+CUR*^3Q>38[!:58-KNCYG$Y3C,+I5CIW1S>11D4D9W=2H';G
MG\J4XR:\65XOEEH>2_=?+)6#(HR*,BC(JP#(HR*,BC(H ,BC(HR*,B@ R*,B
MC(HR* #(HR*,BC(H ,BM+PUXANO"VMPZKIS>5=6[*Q"Y_>+W!YK-R*1<+R#A
MO[W?Z55.<J4E.#LT5"<J<E.#LT??'P_\<6?CKPW::E:OEF4"5.Z/CD5TN3M]
M:^*/@C\2I/A]XGACGE9](O7$<Z'GRV/1Q_6OM&UN8[JW26)@\; %64Y!'K7[
MMDF:0S+#J5_>6Y^SY3F,<?AU-_$MR>EI!2U]&>X%%%% !1110 4444 -6OR^
M_P""C'_)PEI_V![;_P!&3U^H*U^7W_!1C_DX2T_[ ]M_Z,GKS<Q_@?-'S>?_
M .Z?,^7****^4/S,**** "BBB@ HHHH **** "DC^\O^\/\ T*EI(\EE4??W
M ^V-U"TV*CNC]MO@V?\ BT7@C_L"67_HA*[#-<3\&[A1\)/!2D,2NB60R$;'
M^H3VKK_M2>C_ /?MO\*^XIVY$?M-'^''T1/FC-0?:D]'_P"_;?X4?:D]'_[]
MM_A5Z&Q/FC-0?:D]'_[]M_A1]J3T?_OVW^%&@$^:,U!]J3T?_OVW^%'VI/1_
M^_;?X4: 3YHS4'VI/1_^_;?X4?:D]'_[]M_A1H!/FC-0?:D]'_[]M_A1]J3T
M?_OVW^%&@$^:,U!]J3T?_OVW^%'VI/1_^_;?X4: 3YHS4'VI/1_^_;?X4?:D
M]'_[]M_A1H!/FC-0?:D]'_[]M_A1]J3T?_OVW^%&@$^:,U!]J3T?_OVW^%'V
MI/1_^_;?X4: 3YHS4'VI/1_^_;?X4?:D]'_[]M_A1H!/FC-0?:D]'_[]M_A1
M]J3T?_OVW^%&@$^:,U!]J3T?_OVW^%'VI/1_^_;?X4: 3YHS4'VI/1_^_;?X
M4GVQ?[K_ /?MO\*- /R)_;0_Y.;\=_\ 7Q#_ .D:UXQ7LO[9KD_M->.F8;4^
MT6Y^H-LJG'O7C0Z"OC:_\61^-8Y_[34]0HHHKF.,**** "BBB@ HHHH ****
M !>_^^O\UK]P_A[_ ,B'X=_[!UO_ .BEK\/%[_[Z_P UK]P_A[_R(?AW_L'6
M_P#Z*6O<RO>9]OPW\50Z)>E+2+TI:^@6Q]R%%%%, HHHH **** &Y-8/C7QI
MIW@'PWJ&NZO<1VNGV<1D>1VQDC^$>YZ5NNP7D]*_-7]OC]H3_A-/&'_" Z3=
M;M#TML7QA)Q/=?W,YP0O/XYYKDQ%=8>#D]SS<PQD<'1<WOT/#?CS\:-2^.?Q
M NM>U C[!'(ZZ?9X8)%#N.PD$GY]N,GIGM7G.2W+,6;NS=3[TG/=MQ_O>OO1
M7R%2;J2YI;GY+5J2K5'5F[MA1114&84444 %%%% !1110 4444 %%%(3@;F*
MQJ/[YQF@:[+5BT5TO@/X9^+?B=?K:>%O#]YJK%L-.$,<2?\  CU'O7U)\.?^
M";?B75/*N/&.O6NDV[ %K6P7S9QQG&X_+G\#753P]2M\"._#X'$8G2$#XVY!
MW%?W?3<#QGW)QBE@5KIRD,;3L#C$(+_R%?JQX)_8)^$7A.*)[C19O$5RN&\_
M6)C)\W<[%"K^!%>R:+\,_"GAN-4TOP_INGA0%4V]I&I '3'%>C'*Y=9'T%/A
MVJ]:LDC\9=+^&?C'6MK6/A37;M&&5:'3G8$'H1S711_LY_%"1%=? /B#:PR,
MV# X^F:_9F.WC10H' &.F*D6->P%;_V9#^8[8\.4NLV?C!<?L[_%"U4,_@#Q
M!C_KR-8&J?#3QAH:DZCX6UBR Z^=92#'Y"OV_P#+']T4QX8V7!4$'KD4?V9#
M^8<N'*72;/P>EWP2.LJ-#M^]YZ-'@]QR*1) RJ<9W#(*YP?H<<U^X6N_#?PO
MXGA>'5= T^_1_O>=;(Q/XXKQ?QI^P7\)O%GF&VTFX\/7+$MYVDW+1G).>C[E
M ]@!7-/*YKX7<\^MPY67\*:9^4_Z45]E?$C_ ()L^)](BEN?!VNV^M(I)6SU
M >5,1V'F?=)]\#/I7RWXZ^&/BSX97S6WBG0[K1) 2JB:,M')@XRLH^7!['%>
M?/#5:?QH\.O@,3A]*D/F<S13$9Y,';L#=,_,I]@PX/UQ4C J2"-I'49SBN8\
MT2BBB@ HHHH **** "BBB@ HHHH 0#:VY25^E>B? 7XR:I\$_B)9:]8N?LS.
ML-]"<E)82><@$<CM7GE'(Z$@=QZU4)RIN\78WI5I4:JJ1Z'[C>"?&FF^/O"N
MFZ[HUPMS87T*S1NN#M! .TC/!'0BMY6R,U^:/[!W[1)\ ^)&\"ZW*_\ 8FJ$
M-9.QR8IR<$#G 4_3TK]+(]NQ0.!CBOL</65:!^KY?C(XRBIK?J/I:**ZCT@H
MHHH **** "BBB@!H8\T;N<4OK65KNN6WAO2+W5+Z58;6TB>:5F[*H)I:*[8G
M)15V>:_M)?';3O@+\/[K5YW6;5)B8[&S7[TTA&!QW X)^E?D1XBUS4?%6N7^
MKZQ<-=ZM>2-)<7#-D[F)+ >V2:]$_:6^-E_\=/B5>:V[.FAV):'2K<M\@3<0
M) /[S#!/UZ"O+-H7Y1T' KY7&8GVT_=V/RW-\<\95Y4_=0 !0 !@#H****\T
M\.X4444""BBB@ HHHH **** "BBB@ HIK2>7@.,,QXYP?P'4UZ;\-OV<?B%\
M69(CX>\/W(LWP3J.H(;>  ]QGEA].M:TX.KI%&U.C5K.T(W/,RQ_@7>.F<X
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MJT_C1XF(R_%8;6<3B**1=S#(!P.K8XQZBER#RIR.QKF.%+E^(****" HHHH
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M_P 77#T4>UGW#ZQ6_G?WG<?\+T^)/_10?%'_ (.+C_XNC_A>GQ)_Z*#XH_\
M!Q<?_%UP]%'M9]P^L5OYW]YW'_"]/B3_ -%!\4?^#BX_^+H_X7I\2?\ HH/B
MC_P<7'_Q=</11[6?</K%;^=_>7=6UJ_\0:I/J.K7D^J7\QW27%VYDD<[=N2Q
MY)QW/.:HJNU0,YP,9-+16;;;NS"3<G>6X4444A!1110 4444 %%%% !1110
M+W_WU_FM?N'\/?\ D0_#O_8.M_\ T4M?AXO?_?7^:U^X?P]_Y$/P[_V#K?\
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MRV6Y)&-B_>SPP_#M7SE6C.B_>/@\1A*N%GR5$+10O(!ZT5B<04444P"BBB@
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MD"5Y.9?P?F?+\0_[JO4\-HHHKY@_-PHHHH **** "BBB@ HHHH *_:/]GO\
MY(/\._\ L7=/_P#2:.OQ<K]H_P!GO_D@_P ._P#L7=/_ /2:.O<RSXY'V/#G
M\2?HCT.BBBOH3[\**** $]:_.?\ X*>?\CYX0_[!D_\ Z'7Z,>M?G/\ \%//
M^1\\(?\ 8,G_ /0Z\[&_P6>!GG^Y2/C-OO&DI6^\:2ODC\M6P4444QA1110
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MVP-V .*^?N>XVGTSG'XU\[4IRIRY9(_/\1AJF%J<E1!1116)RA1110 4444
M%%%% !1110 DB+*H#C< <@>E?4O[!7QR'PZ^(;^%=2N/+T77.8U.2(KC. 1S
MQN[]>M?+=2VES-87D%U;RM#<02I-'(IP593D5M2JNE-31UX3$2PU>-5'[OJV
M5!HW')KR[]F_XKQ_&3X0Z#K^1]N:$6U[@8 N8P%EP"2<%@2/8UZ@K!E!Z<5]
MG":G%21^P4IJK!3CU'"EI!TI:T-0HHHH **** "BBB@ HHHH **** "BBB@
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MC3'KDY!^4U]7:=I=MI=G%:VD2P6\2A$C0   < 5+;VT5M;QPQ(L<4:A511@
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MF/\  ^:/F\__ -T^9\N4445\H?F84444 %%%% !1110 4444 %%%% !1110
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MBY=LG!;Z#O5:WY4KEJ,JDE""+/@WPAJ_COQ)::'HME)J%_=,$2&'K'G^-O\
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MJ(4444 %%%% #>QK\C?VY/\ DZ3QM];'_P!($K]<NQK\C?VY/^3I/&WUL?\
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M(_\ R17WHMNNT?*,8]!2_9U_NC\A7TWU&A_*?HO]C8+^0^"O^'7[_P#11O\
MRA'_ .2*/^'7[_\ 11O_ "A'_P"2*^]?LZ_W1^0H^SK_ '1^0H^HT/Y0_L;!
M?R'P5_PZ_?\ Z*-_Y0C_ /)%'_#K]_\ HHW_ )0C_P#)%?>OV=?[H_(4?9U_
MNC\A1]1H?RA_8V"_D/@K_AU^_P#T4;_RA'_Y(H_X=?O_ -%&_P#*$?\ Y(K[
MU^SK_='Y"C[.O]T?D*/J-#^4/[&P7\A\%?\ #K]_^BC?^4(__)%'_#K]_P#H
MHW_E"/\ \D5]Z_9U_NC\A1]G7^Z/R%'U&A_*']C8+^0^"O\ AU[+_P!%'_\
M*$?_ )(KU?\ 9K_8Q?\ 9^\<7_B+_A*O[=^T6!L/(_LXVV 7#ELF1N<C\J^G
MO)7V_P"^1_A3A& ,9S^'Z54<+1@^:*LS>GE>%I24X0LT.7.T9&#Z4ZD4!5
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M.R^#_P -Y?B/XD0'?'I=JX:Z<='QT49'7UK[7T_38-+LH;6VC6*") BQJ,
M# KF?AGX#M? ?ABSL(E_?!0\[\9:0CYCTZ9Z5V(K]UR+*HY=A]5[TMS]DR?+
M8Y?1NU[SW#9D#FEQVHI:^E/?"BBBF 4444 %%%% !1110 4444 %%%% !111
M0 4444 -VT;?>G44!L,*Y.:^>_VCOA,;VW'B/28MMS%DW,2@89>I;ZU]"U%=
M6T=U"\<R"2-AM96Y!%>9F&!IYC0=&I\CAQV$CC:+HS6^Q^<ZN&4,.A&:7(KT
M;XY?#A_ ?BQWMEQI=ZSRQ$CA"224&.P[5YPKAE# %0><-U%?@.+PE3!UY4)]
M#\2Q6&G@ZSHU!<BC(HR*,BN4Y0R*,BC(HR* #(HR*,BC(H ,BC(HR*,B@!DB
M+(""2.G3M7V!^S9XN/B#P#%9R2^9<Z>Q@*GKL'"_I7R%D5ZW^S/XI&C_ ! D
ML6;;!J,.U-W3S%_QKZ;AS%_5,=%-Z2T9]'D&*^KXU1;TEH?82\ 4M(.E+7[J
M?L04444 %%%% #5K\OO^"C'_ "<):?\ 8'MO_1D]?J"M?E]_P48_Y.$M/^P/
M;?\ HR>O-S'^!\T?-Y__ +I\SY<HHHKY0_,PHHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH %[_ .^O\UK]
MP_A[_P B'X=_[!UO_P"BEK\/%[_[Z_S6OW#^'O\ R(?AW_L'6_\ Z*6O<RO>
M9]OPW\50Z)>E+2+TI:^@6Q]R%%%%, HHHH \K_:4^)<?PI^#/B77F91/';M#
M;A\\RO\ *HX(]<_A7XW%KB3+74C2W#$M*[=2Y^\?J3FONG_@II\0B\GA?P7;
MS*WS-J-W$,]N(PW/3J:^%CG^(Y;N:^7S&IS5.4_-\^Q'M<1[/HOS$^@P****
M\D^7"BBBF 4444 %%%% !3E7<&"C<RC+'. /2FUV7P;^%]]\:/B#I?ABP&XW
M$PDN'.=J0H?GR?7 -5&/M&HK<THTY59*G'5L]Y_8<_9I3XGZ\OC+Q';%_#>E
M38M;1UXN+E3RQX^90>GX5^FJ0K&J@<!1C:.!6)X)\&:9X!\*Z;H6CVXM[&QA
M2&, #)"J!N; &6.,DUO8.*^PPV'CAX66Y^L9?@XX.BHK=[CMM&*!2UU^IZ@4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% ";:,4M% $<L231ND@W(
MPVE6&0:_,_\ ;H_9I'PY\17'CGP];!?#^JW :[AC7Y;6XYRQXX5B37Z9=<U@
M^-?!VG>/?#6H:%JULEU8WL+121R+D>Q^H//X5R8BA[:%NIYF/P<,91<&M>A^
M'(78-N-N.-I.<45W/QN^%6H?!?XD:IX7OMSI&S2V-PP_U\&X["3_ 'MN,X[]
MJX?\,?6OD)Q=.3@T?DM6G.E)PENA****S("BBBF 4444 %%%% #HW:-XW0E7
MC8.C#JK!MP(]\U^R/[-/Q*3XJ_!KPWK8D$ET+5;:[QG_ (^(U"R=3_>!/XU^
M-E?=7_!,WX@$7'BOP9-,H52E_;1GKR/GQVZG/2O6R^IR5'%]3Z?(,0Z>(]FW
MHS[['2EI%Z4M?3GZ2%%%% #"NXU\<?\ !2+XF/H/PYTWPC9S!+S6[D>:%SO$
M*\DCGN?7-?8SMM1NY%?DE^VU\0F\>?M!:XL$FZST/&EQ@9X=21*>O7<#7FX^
MHZ=*R>Y\_G.(]AAFD]9'A7'\(VKV7THH&<<]:*^3L?F&H4444Q!1110 4444
M %%%% #58^9M88!(*D#.1G&W_>)Z5^E7[#?[,"_#SP^OC7Q%:!?$^IQJ]M'(
M ?L<#+D  C(<@_-SU!X%?-O[#OP$'Q6^('_"0ZM"9/#.AL)&20?)-< _*O(Y
M (R?I7ZF(@50%& .E>_@,+;]]/Y'W&19=I]8JKT'>6, 9X% 7'?-*O"@9S[F
MEKWC[@**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH :%K&\7
M^$],\;>'+[1=7M4O=/O(S'+#( 00>_U'6MNBDTI*S%**DG&6Q^-W[27P-O\
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M(*RIXKE_F/O6EI!TI:^H/TP**** "BBB@ HHHH **** "BBB@ HHHH ****
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M-S'^!\T?-Y__ +I\SY<HHHKY0_,PHHHH **** "BBB@ HHHH **** "BBB@
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MY4HKH?L%."IQ4([(2EHHJBPHHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M?^">_P#R<5;?]@Z?^M=6%_CQ/3R[_>J?J?J@OW1]*6D7[H^E+7V9^NA1110
M4444 %%%% !1110 4444 %%%% !1110!X5^VO_R;/XX_Z]%_]&+7Y(/]YOK7
MZW_MK_\ )L_CC_KT7_T8M?D@_P!YOK7SF9?QH^A^><1?[Q'T&T445XI\D%%%
M% !1110 4444 %%%% "22+&CD\D*S#WP!C]37ZZ_L=?#D_#GX$>&[:50MU?P
MG4KC YW3?.JGZ*P_*ORF\#^'3XL\;>'M$56=K[4X8#LZF-B&;\>*_<*QM8[&
MSAMXE$<4:!%51@  8 %>YEE/5S/M.'*"<IUBPO  I:2EKZ$^\"BBB@ HHHH
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MGTB_=%+7VQ^QA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M^M4?YD']I83_ )^(^K.:.:^4_P#AY#\*_P#GUU__ , !_P#%T?\ #R'X5_\
M/KK_ /X #_XNCZU1_F0?VEA/^?B/JSFCFOE/_AY#\*_^?77_ /P '_Q='_#R
M'X5_\^NO_P#@ /\ XNCZU1_F0?VEA/\ GXCZLYHYKY3_ .'D/PK_ .?77_\
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M^M=6%_CQ/3R[_>J?J?J@OW1]*6D7[H^E+7V9^NA1110 4444 %%%% !1110
M4444 %%%% !1110!X5^VO_R;/XX_Z]%_]&+7Y(/]YOK7ZW_MK_\ )L_CC_KT
M7_T8M?D@_P!YOK7SF9?QH^A^><1?[Q'T&T445XI\D%%%% !1110 4444 %%%
M% 'L_P"QII*ZM^TIX-CD7?'#)+<_\"53C\*_7R,;E#>HK\JOV ;=+C]HK36?
MK#8W+KCUP17ZK1\1J/85]/EJ_<W/T?AU6PKMW%I:**]8^I"BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH ::Q_$U@FJZ#JMC*,Q74$D+8ZX:,@UL-
M5>[7=#(01N&2,^N*B6S)FKP9^$TT;1RNCC:ZL00.QIE;'C&U%CXNURV'2&^G
MC_*1A_2L>OAY?$S\5J?'+U"BBBI,PHHHH **** "BBB@ KI?A?=-9_$[P?=*
M<26NKVTB>A(?//YFN:K3\*W#6?BK1KE "\-Y!*H;IGS0O/X5=-_O%ZG11TJQ
M?H?NA&<QJ?:GU'!_J4^E25]RMC]FCL@HHHIE!1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 UC7AW[6%Z8? ]G;C'[V[7],U[@U?.7
M[7%Y(MOX?MN/+:624^N1T_#FO SV?)EU5^1XF<R<<#5:['SCQVZ49%(#P*7(
MK\#]#\5#(HR*,BC(H ,BC(HR*,B@ R*,BC(HR* #(I#D;_;[O_?(/\S2Y%36
M,)OKZUM_^>LR1G;UY8?T%53CS3C'O8JG%RFH^A]U?#+0TT?X?:#9@,C+9QE_
M7>R@M^I-=9MYS4.GQB*RA4#&%'%6*_I*A%4Z4(+HD?OM&*A2C!=$%%%%;FP4
M444 )UXJE?J&MW4\CYA^E7.]5+[_ %,GX_\ H-95/@9,_@9^?&J.?[2N\' \
MY^ !Q\QJKO/][]!5G5"/[2N_^NS_ /H1JMD5_-U;^++U9^!5OXDO5AO/][]!
M1O/][]!1D49%9&(;S_>_04;S_>_049%&10 ;S_>_04;S_>_049%&10 ;S_>_
M04;S_>_049%&10 ;S_>_04;S_>_049%&10 ;S_>_04;S_>_049%&10 ;S_>_
M04;S_>_049%&10 ;S_>_04;S_>_049%&10 W:#R<?]\C_"DV@]<$=1E1Q^E/
MR*,BD"TV L#S1D49%&13 ,BC(HR*,B@ R*,BC(HR* #(HR*,BC(H ,BC(HR*
M,B@#T+]GN^:Q^+6E8(Q<))"<^F"?SK[9&<#/7%?"7PCN1:_$SPY(#RMT%Y]&
M'-?=WI7Z_P (SY\'*/9GZGPM)O"-/HQ12TE+7WA]D%%%% #5K\OO^"C'_)PE
MI_V![;_T9/7Z@K7Y??\ !1C_ ).$M/\ L#VW_HR>O-S'^!\T?-Y__NGS/ERB
MBBOE#\S"BBB@ HHHH **** "BBB@ HHHH **7:_91C\?\*-K_P!T?F?\*D5G
MW$HI=K_W1^9_PHVO_='YG_"@+/N)12[7_NC\S_A1M?\ NC\S_A0%GW$HI=K_
M -T?F?\ "C:_]T?F?\* L^XE%+M?^Z/S/^%&U_[H_,_X4!9]Q**7:_\ ='YG
M_"C:_P#='YG_  H"S[B44NU_[H_,_P"%&U_[H_,_X4!9]Q**7:_]T?F?\*-K
M_P!T?F?\* L^XE%+M?\ NC\S_A1M?^Z/S/\ A0%GW$HI=K_W1^9_PHVO_='Y
MG_"@+/N)12[7_NC\S_A1M?\ NC\S_A0%GW$HI=K_ -T?F?\ "C:_]T?F?\*
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M\W"BBB@ HHHH **** "BBB@ K]H_V>_^2#_#O_L7=/\ _2:.OQ<K]H_V>_\
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M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 -J"ZC'EL>AY/Z5/\
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M*,BC(H ,BC(HR*,B@ R*,BC(HR* #(HR*,BC(H ,BC(HR*,B@ R*,BC(HR*
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ME7PX_8+^%/B7X?\ AG5KZSU)[V^TRVNIW6\(#2/$K,<8XY)KH_\ AW?\'_\
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M#C_A7TU11]7I?RH/[/PO_/M'S+_P[O\ @_\ \^&I_P#@<?\ "C_AW?\ !_\
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M/_\ /AJ?_@<?\*/^'=_P?_Y\-3_\#C_A7TU11]7I?RH/[/PO_/M'S+_P[O\
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M^;Z2EI*^7/S0**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@_\ 1PJJ?\1>IT4OXD?D?NG#_J4^E25'#_J4^E25]TMC]FC\*"BBBF4%%%%
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M,GKS<Q_@?-'S>?\ ^Z?,^7****^4/S,**** "BBB@ HHHH **** "DC^\O\
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M8?\ H9_2O,S#^ SY[/4G@WZGQ]11TX'2BOE3\P"BBB@ HHHH **** "BBB@
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M?]@2R_\ 1"5V-?=0^%'[31_AQ]$%%%%6:A1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M3I/&WUL?_2!*\G,OX/S/E^(?]U7J>&T445\P?FX4444 %%%% !1110 4444
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M_P#\31_PRAXD_P"@GIW_ 'T__P 37U7L7W_.C8OO^='^J^6_RO[P_P!7<O\
MY7]Y\J?\,H>)/^@GIW_?3_\ Q-'_  RAXD_Z">G?]]/_ /$U]5[%]_SHV+[_
M )T?ZKY;_*_O#_5W+_Y7]Y\J?\,H>)/^@GIW_?3_ /Q-'_#*'B3_ *">G?\
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M^(?_ $C6O&*]G_;0_P"3G/'?_7Q#_P"D:UXQ7Q=?^+(_'L=_O-3U"BBBN8X
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MMB;_ .)K](]H]_SHVCW_ #H_L^AV#^P\%V?WGYN?\.SO'O7_ (270C[8F_\
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M'9WCWK_PDNA'VQ-_\37Z1[1[_G1M'O\ G1_9]#L']AX+L_O/S<_X=G>/>O\
MPDNA'VQ-_P#$T?\ #L[Q[U_X270C[8F_^)K](]H]_P Z-H]_SH_L^AV#^P\%
MV?WGYN?\.SO'O7_A)="/MB;_ .)H_P"'9WCWK_PDNA'VQ-_\37Z1[1[_ )T;
M1[_G1_9]#L']AX+L_O/S<_X=G>/>O_"2Z$?;$W_Q-'_#L[Q[U_X270C[8F_^
M)K](]H]_SHVCW_.C^SZ'8/[#P79_>?FY_P .SO'O7_A)="/MB;_XFC_AV=X]
MZ_\ "2Z$?;$W_P 37Z1[1[_G1M'O^=']GT.P?V'@NS^\_-M?^"9OQ Y+>)=
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M48I:* $Q1BEHH 3%&*6B@!,48I:* $Q1BEHH 3%&*6B@!,48I:* $Q1BEHH
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M-M+10 FVC;2T4 )MHVTM% ";:-M+10 E+110 4444 1LOS?ABOR:_;@^':^
M/CYK,MM$8;'6PNHP-C@SL29!],D^_O7ZS=,U\D_\%#OA>WBKX7VOB:UC\V_\
M/W'FR8'6%^#GOQQW[UYV-I.I2/!SK#?6,*VMXZGYI[1'\HZ+Q24BXVC!R,<&
MEKY/8_+0HHHH **** "BBB@ H;Y@HZ  @@=\G/-%%(#[K_X)W_'J.)I?AKK%
MSEW9[K2Y)#R1U>+).,#L .W>OO@=*_"C1]6O-!U2SU+3[A[2]M)EGAFC."I!
MSCZ'O7ZZ?LP_'[3_ (\?#ZTOQ)%%KEJJP:C:ID;)@ &9023L)SC)/UKZ7 XK
MVB]G-ZGZ'D>8*I#ZO4>JV/9:6DI:]D^M"BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** &Y-&[\Z7O5>XN4M=SRLJHJEF9C@*H[FAM+<6VK.;
M^)7Q"L/AEX+UCQ%JTJPVNGPM(2W <_PJ.>23@5^-?Q+\?7_Q5\<:UXHU-V:?
M4Y6=(SG;;QEBRH@))  (')/2O>OVX/VCC\5O%G_"+:'=&3PSI$K"4QY"W4X8
MJ=QSAE!'&,5\P<_Q<GO7S./Q'M'R+8_-\ZS#ZQ5]A!^ZA3[#'L*2BBO'/F H
MHHI@%%%% !1110 4444 %??7_!,'_D%^/?\ KZM?_19KX%K[Z_X)@_\ (+\>
M_P#7U:_^BS7I8'^.CW\D_P!]B?=:]*6D7I2U]6?J(4444 %%%% #>QK\C?VY
M/^3I/&WUL?\ T@2OUR[&OR-_;D_Y.D\;?6Q_]($KR<R_@_,^7XA_W5>IX;11
M17S!^;A1110 4444 %%%% !1110 5^T?[/?_ "0?X=_]B[I__I-'7XN5^T?[
M/?\ R0?X=_\ 8NZ?_P"DT=>YEGQR/L>'/XD_1'H=%%%?0GWX4444 %%%% !1
M110 4444 (>]>/\ [6W_ ";IX[_[!Y_]"%>P'O7C_P"UM_R;IX[_ .P>?_0A
M6-7X)>C.7%?P)^C/QY3[J_2EI$^ZOTI:^(/QI[A1110(**** "BBB@ HHHH
M*^E?^">__)Q5M_V#I_ZU\U5]*_\ !/?_ ).*MO\ L'3_ -:ZL+_'B>GEW^]4
M_4_5!?NCZ4M(OW1]*6OLS]="BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M#PK]M?\ Y-G\<?\ 7HO_ *,6OR0?[S?6OUO_ &U_^39_''_7HO\ Z,6OR0?[
MS?6OG,R_C1]#\\XB_P!XCZ#:***\4^2"BBB@ HHHH **** "BBB@#Z4_X)\?
M\G$6W_8.G_K7ZGKVK\L/^"?'_)Q%M_V#I_ZU^IZ]J^HRW^ ?I7#_ /NH^BBB
MO5/I@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** &_P"-177^I;Z'
M^52_XU%=?ZEOH?Y4GL3+X6?A_P#$#_D??$G_ &$[G_T:U8%;_P 0/^1]\2?]
MA.Y_]&M6!7PU3XV?B];^)+U84445!B%%%% !1110 4444 %7] _Y#VF_]?$'
M_HX50J_H'_(>TW_KX@_]'"JI_P 1>IT4OXD?D?NG#_J4^E25'#_J4^E25]TM
MC]FC\*"BBBF4%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M-:%>*G!Z#Z***U-@HHHH **** "BBB@ HHHH **** "BBB@ HHHH ;NI::6
M/N>E59M3A@D*O-&A'\+.H)_6E=+<-.I<YHYK.&M0'^-/^_B?_%4?VU!_?3_O
MXG_Q5,CVD.YH\T<UG?VU!_?3_OXG_P 51_;4']]/^_B?_%4![2'<T>:.:SO[
M:@_OI_W\3_XJC^VH/[Z?]_$_^*H#VD.YH\T<UG?VU!_?3_OXG_Q5']M0?WT_
M[^)_\50'M(=S1YHYK._MJ#^^G_?Q/_BJ/[:@_OI_W\3_ .*H#VD.YH[J-U9W
M]LP?WT_[^)_\52?VU!T$L;'&20Z<<]_FHT'S1[FG13(I/,7/;MBGT%!1110
M4444 -VUE>)O#]KXH\/ZCH]W&)+:]A>WD! /#*1G\,UKTFWWI-75F3**DK,_
M$'XJ>![KX6>/]=\-7R,9-,G=<J,;XMY"./8C!KF678Q4D-@XR.AK[U_X*/?!
MMS!IOQ(T^$R?9O\ 0]32,<M&>$;\.A_"O@G9Y?R;@VWC<.A]Z^,Q-%T:K1^3
M9EA?JM>4=D%%%%<QY04444 %%%% !1110 5WWP2^,FK_  3\<6OB'2B\B*ZQ
MWEJ"=LT.>01GD^E<#1CY]QY.,549.+YEN;4ZDZ4E.#LT?MI\*_BEHGQ:\'V6
MO:'=)-!,@\R-2"T#X!,;#L1T_"NPW5^-O[/?[0&M_L^>*H[W3#]LT:X8"^TQ
MBQ0@GEP,CY^^>GM7ZO?"OXL>'_B_X7MM;T"[6>*1%\V+/SP2$ F-AV()P?H:
M^JPF*C7C:6Y^FY7F4,;27,[2.VHI!TI:]$]T**** "BBB@ HHHH **** "BB
MB@ HHHH **** &EC2[OSH[U"TFS<6X Z$]Z%IN+S8]F*_3N?2OAW]N+]JY=(
M2Z^'?A.]4:G<*1J6H0](8\D&)6!X;L<YK3_:Z_;0M_"]K>>#/!$\-YKDRO'=
M:DA)BM1DAE!##YQ^7M7YW33S7TDLUS<274UPYEFFE.6E8G)9CZD\UX>.QJBO
M9T]SXS.,WC&/L*#U?48HPH"LP'7D\GZTHX %+25\]=O5GPEWU"BBB@04444
M%%%% !1110 4444 %??7_!,'_D%^/?\ KZM?_19KX%K[Z_X)@_\ (+\>_P#7
MU:_^BS7I8'^.CW\D_P!]B?=:]*6D7I2U]6?J(4444 %%%% #>QK\C?VY/^3I
M/&WUL?\ T@2OUR[&OR-_;D_Y.D\;?6Q_]($KR<R_@_,^7XA_W5>IX;1117S!
M^;A1110 4444 %%%% !1110 5^T?[/?_ "0?X=_]B[I__I-'7XN5^T?[/?\
MR0?X=_\ 8NZ?_P"DT=>YEGQR/L>'/XD_1'H=%%%?0GWX4444 %%%% !1110
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M59C^]IUQG\,U^J"]J_+'_@GN%?\ :*M>N5TRX/ZD5^IJ?=6OJ,M_@'Z5P_\
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MJ)[6V8$/=2##X]5YX_$&O$S#.,+ET+U97?9'EXW,\/@HWG*[['KOQ2^-FD>
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M7_BR/Q['?[S4]0HHHKF. **** "BBB@ HHHH **** !>_P#OK_-:_</X>_\
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MU-&?>9?GL:K5+$Z/N?H>K9]Z-U<UX'^(OASXBZ-%J7AS5[75;5U#;H&Y7(R
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M+1117JGT@4444 %%%% !1110 4444 %%%% !1110 4444 %%%% #?\:BNO\
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MY/\ DZ3QM];'_P!($KR<R_@_,^7XA_W5>IX;1117S!^;A1110 4444 %%%%
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M9%&11D4 &11D49%&10 9%&11D49% !D49%&11D4 &11D49%(6PVT+O(&6.<
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M#3_\:9-]TTGL3+9GXF?%_GXM>-C_ -1N^_\ 1[UR-==\7O\ DK/C7_L-WO\
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M1D49% !D49%&11D4 &11D49%&10 9%&11D49% !D49%&11D4 &11D49%&10
M9%&11D4-G(('R?7DFCM?<7516K JRQECMPIR6SP!V_&O1/A!\'[GXD:EY]VK
M0Z+&REWQ@R8[+6A\'_@;=^.+Q=1U2%[+10RL$;AYL<@\\;3]*^N=+TBTT6UB
MM;*!+>",;5CC4 "OO,BX=EB9+$8E6CV[GW&3Y#*N_;XGX>PNCZ+:Z+IMM962
M""WA1415&/E P!5[;2BEK]<C",(J,59(_3(Q48J,5HA*6BBK*"BBB@ HHHH
M**** "BBB@!JU^7W_!1C_DX2T_[ ]M_Z,GK]05K\OO\ @HQ_R<):?]@>V_\
M1D]>;F/\#YH^;S__ '3YGRY1117RA^9A1110 4444 %%%% !1110 4D?WE_W
MA_Z%2TD?WE_WA_Z%1 J.Z/VV^#?_ "2+P1_V!++_ -$)78UQWP;_ .21>"/^
MP)9?^B$KL:^ZA\*/VFC_  X^B"BBBK-0HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@#\@/VT/\ DYSQW_U\0_\ I&M>
M,5[/^VA_R<YX[_Z^(?\ TC6O&*^+K_Q9'X]CO]YJ>H4445S' %%%% !1110
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MR/L>'/XD_1'H=%%%?0GWX4444 %%%% !1110 4444 (>]>/_ +6W_)NGCO\
M[!Y_]"%>P'O7C_[6W_)NGCO_ +!Y_P#0A6-7X)>C.7%?P)^C/QY3[J_2EI$^
MZOTI:^(/QI[A1110(**** "BBB@ HHHH *^E?^">_P#R<5;?]@Z?^M?-5?2O
M_!/?_DXJV_[!T_\ 6NK"_P >)Z>7?[U3]3]4%^Z/I2TB_='TI:^S/UT****
M"BBB@ HHHH **** "BBB@ HHHH **** /"OVU_\ DV?QQ_UZ+_Z,6OR0?[S?
M6OUO_;7_ .39_''_ %Z+_P"C%K\D'^\WUKYS,OXT?0_/.(O]XCZ#:***\4^2
M"BBB@ HHHH **** "BBB@#ZA_P""<_\ R<%<?]@67_T97ZB>E?EW_P $Y_\
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M"16VC=@]C@X^E&0W(Z5Y)\U)2CN@HHHH$%%%% !1110 4444 %%%% !1110
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MHGI7Y=_\$Y_^3@KC_L"R_P#HROU$]*^HRW^ ?IF0_P"YKU%HHHKU3Z0****
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M** &K7Y??\%&/^3A+3_L#VW_ *,GK]05K\OO^"C'_)PEI_V![;_T9/7FYC_
M^:/F\_\ ]T^9\N4445\H?F84444 %%%% !1110 4444 %)']Y?\ >'_H5+21
M_>7_ 'A_Z%1 J.Z/VV^#?_)(O!'_ &!++_T0E=C7'?!O_DD7@C_L"67_ *(2
MNQK[J'PH_::/\./H@HHHJS4**** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH _(#]M#_DYSQW_ -?$/_I&M>,5[/\ MH?\
MG.>._P#KXA_](UKQBOBZ_P#%D?CV._WFIZA1117,< 4444 %%%% !1110 44
M44 "]_\ ?7^:U^X?P]_Y$/P[_P!@ZW_]%+7X>+W_ -]?YK7[A_#W_D0_#O\
MV#K?_P!%+7N97O,^WX;^*H=$O2EI%Z4M?0+8^Y"BBBF 4444 %%%% !1110
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M-27Q*Q\O*$J;_>*PZBCK_P#KS100%%%% !1110 4444 %%%% !1110 4444
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M\&?J S%<CCV_^O7Y&_MJ>,H_&'[1WB*6U/FQ:<\>GKMY!:,88?\ ?>:_0?\
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M+<-@_P"%!(^MH8+#896I02&^4N ,=*=M'2BEKU3M&[?>C;QC-.HH 0<4M%%
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M)]X@_P# ,_XT>QJ=@^J5_P"5GG%%>C_\,W_%3_HGWB#_ , S_C1_PS?\5/\
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MXOU;1?!VLZII]T\3)<6]J2C$1B,X.>1@9^OY5Y*O[./Q29B!X!U[&>/]#/\
MC7QU>$_:R]T_)<7AZT\1-J+W/.:*]'/[-_Q4S_R3[Q ?^W,_XT?\,W_%3_HG
MWB#_ , S_C6'L:G8XOJE?^5GG%%>C_\ #-_Q4_Z)]X@_\ S_ (T?\,W_ !4_
MZ)]X@_\  ,_XT_8U.P?5*_\ *SSBBO1_^&;_ (J?]$^\0?\ @&?\:/\ AF_X
MJ?\ 1/O$'_@&?\:/8U.P?5*_\K/.**]'_P"&;_BI_P!$^\0?^ 9_QH_X9O\
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MZW_P33\<VH<Z7XDT?4 "=OG1R0EAV)'.#[9./4UP>K?L&_&33=P@T&SU':<
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M-<ECW8JQV#/7 4#T %=L,MJ2WT/2IY!B:GQ:'Y2^&_!^N>,;@6^B:1>ZG.>
MMK;O)^H&/R)KWGX>_L$?$[QEY4^JPVWA6S8!B;XEY,$9^X""I]CTK]0M)\-Z
M7H-HEMIFGV^G6RJ$6&TB6)0 ,  *!C%7XX1&,+N_%B?YUV4\M@OB9[E#AVC3
M_B2N?*OPO_X)Y?#WPJMM>>(S/XKU*/#[+APMLK>JHH!ZY^\37TWH?AG2_#-B
MEGI5C;Z?;( HCMXP@P!@=*T\>]%>K3I0I_"CZ.CA:.'_ (<4AHC"].OK3@,4
MM%:G4)MHI:* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@!-M&VEHI -*^^*IZIH=CK5C)9W]K#=VDB[7AF0,
MC#W!J]13$TI*S/ESXJ?\$_?AQXZ6>[TF*;PKJ9+.'T_!A+$DY:-L\>RD5\I?
M$+]@/XE>$%DN=(2V\4V2Y(^QYCE9>QV$^G;FOU-*[N_ZTUHER#SGU!Q7!4P-
M&IJE8\7$91A<1NN7T/PR\1>%-<\'W+0Z_I%_H<BY!%]:.JY'^UTQ[UE1MYB
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MC_\ #-WQ67AOA]KV1UVVA8?@>X]ZF@_9E^*]QPO@#6D]W@(I>QJ?RF7U2O\
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M?-Y[3E4PJC!7=SY7HKT9?V</BH5!'P_U]AV(LSS^M+_PS?\ %3_HGWB#_P
MS_C7S7L:G8_//JE?^5GG%%>C_P##-_Q4_P"B?>(/_ ,_XT?\,W_%3_HGWB#_
M , S_C1[&IV#ZI7_ )6><45Z/_PS?\5/^B?>(/\ P#/^-'_#-_Q4_P"B?>(/
M_ ,_XT>QJ=@^J5_Y6><45Z/_ ,,W_%3_ *)]X@_\ S_C1_PS?\5/^B?>(/\
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M (J?]$^\0?\ @&?\:/8U.P?5*_\ *SSBBO1_^&;_ (J?]$^\0?\ @&?\:/\
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MT?\ #-_Q4_Z)]X@_\ S_ (T>QJ=@^J5_Y6><45Z/_P ,W_%3_HGWB#_P#/\
MC1_PS?\ %3_HGWB#_P  S_C1[&IV#ZI7_E9YQ17H_P#PS?\ %3_HGWB#_P
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M 2C;[TM% ";:0J",4ZB@!H7%!CW=Z=10 W:*-HIU%*R ;Y:_Y-+M'I2T4<J
M9Y*GJ,TNS@ ' IU%,!GECTYI=ON:=10(3%%+10,**** "BBB@ HHHH ****
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MQ_D4^B@!GEBA8PO3COUI]% !1110 4444 %%%% #2N:3RQP2,FGT4!N,$84
M=?K1Y8_R*?10 SRQ_D4>6/\ (I]% #/+'^11Y8_R*?10 SRQ_D4>6/\ (I]%
M #/+'^11Y8_R*?10 WRQ2XI:*5@"BBBF 4444 %%%% !1110 4444 )BD" #
M Z4ZB@!OEC_(I/+'^13Z* &>6/\ (H\L?Y%/HH 9Y8_R*/+'^13Z* &>6/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
G"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>ehealthlogo1.jpg
<TEXT>
begin 644 ehealthlogo1.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" !" ,T# 2(  A$! Q$!_\0
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M;:-+:W-QJ\-PT<%LZ1*QE4G&<X'7OWKB_P#@IU_R6?PW_P!@%/\ THGKZ]^
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MI1QD%AUS8R46E;EY?P[6.4_8$T;Q)H/[2&E/)I6H6-E<V5W#=236SHGE^47
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M\% _"OF3_@J%_P E$\&?]@J3_P!'&OI_]A'_ )-3\#_]OW_I=<4J7^]3]/\
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D4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover Page<br></strong></div></th>
<th class="th"><div>Jul. 28, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jul. 28,  2025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">EHEALTH, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-33071<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">56-2357876<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">13620 RANCH ROAD 620 N, SUITE A250<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">AUSTIN<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">TX<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">78717<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">737<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">248-2340<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.001 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">EHTH<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001333493<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="ehth-20250728.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ehealthinsurance.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" original="ehth-20250728.htm">ehth-20250728.htm</File>
    <File>ehth-20250728.xsd</File>
    <File>ehth-20250728_lab.xml</File>
    <File>ehth-20250728_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="24">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>17
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "ehth-20250728.htm": {
   "nsprefix": "ehth",
   "nsuri": "http://www.ehealthinsurance.com/20250728",
   "dts": {
    "inline": {
     "local": [
      "ehth-20250728.htm"
     ]
    },
    "schema": {
     "local": [
      "ehth-20250728.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "ehth-20250728_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "ehth-20250728_pre.xml"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 23,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2025": 24
   },
   "report": {
    "R1": {
     "role": "http://www.ehealthinsurance.com/role/CoverPage",
     "longName": "0000001 - Document - Cover Page",
     "shortName": "Cover Page",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ehth-20250728.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ehth-20250728.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment Flag",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "City Area Code",
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Period End Date",
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line One",
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, City or Town",
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Postal Zip Code",
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, State or Province",
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Central Index Key",
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Emerging Growth Company",
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity File Number",
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Incorporation, State or Country Code",
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Tax Identification Number",
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Local Phone Number",
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Issuer Tender Offer",
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Tender Offer",
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of 12(b) Security",
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security Exchange Name",
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Soliciting Material",
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Symbol",
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Written Communications",
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>18
<FILENAME>0001333493-25-000083-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001333493-25-000083-xbrl.zip
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M+ " "U2U/:6(,%GD7JU[A-KD&0T<0^1'&H/BE@#L0IF.:>,3]1*C(I +VF_
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M%*2$NPGV4S2FI=[$+>8DXGQ8E2[,TL2%,8 _% PX*( !'C(B)<QUDOR"*FS
M!):GHD'BZP:B2!1Q'D<%8*[5PB*63L *SW7,765H>W3\J0Y#9B)!W>59#6A
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MF9-9_VM\P[-WY_VKSY>GPVTN0,VH>-8\TO)I.5U6E%V MM6NB'JQ=#NJA_Z
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MDIUFII,?OG]Z>+C_XNO-@09[;AHXC?06FW1R56G-%W(KNT+[<?!BE)@ZH<L
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ME6D:X)A%V9@4?EO2^TKBE@M5-<LQ+Z=DYEFV37*JVEKC![^699:\UZJ&<79
M<FF5SH"SPG_PE2CE,CV%+48IEURBM( ?'L.4\O)F-$YH^C#0@C[7AMX)TB]<
M,+S%[0;LS.OR1E_K:HQR$K3QM#(3'IWVP<GW<;"%L@GP*>K@&:ZPQC%4 <N=
MZ )FV.!@"UT@5?*NX!124X'Z7C?X0Y+*JV=N=Q;G#S^(#O&N<8/#X7"#2W<^
M+^5\ML4-[KQ=L*-&0SC6P[W]0US^>7%=YFW1J&J9? @NSUNZ^\#1BF0*5]YQ
MF-][?SV-><_V1,7Y--DQHX#9.%9;)\B08)ZXKDVB80=^@_\+O!:_A[^<:KKL
M,,,1+5SD1[!^*T-VE&>X\%IM"F"R\,2.@3G^Z7<&2]HH]'!NI3]&F2:=Y,8)
MHHCS&UC#]:GILZR$-X)4 I%V78+>J1)DQ9FJ,A1RL'"-4TUS9>;UZK:"2% X
MI3DM#1YLC,KS)8P/1* JEG,H#9L&A);,!SZ$&6[EOJ :.S,3TR0G#R9[,*OW
M?-3;MH)V;F;&ZC9$589,R'^!3H.D=(67<:J0".=E9J8F948%5FE(E/#+%/X)
M9$CTR@9K,FV1,'4!XZ9:37*=M" QX(8N%K!']$&N;N@FPP"5GN;XUO!;?:7R
M)(5;=X7&[.HMA?M2RHR0Q N^IO]J*U-GAK2R\0_?'SS>?['Z:*V!2?"C<*5
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MR"M,?KW.]^ @W7_QZ!XY2 >AC \E&,(V]!^=PLDH?;MFXVH7=,ZP$,H*GDA
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M[7N"3W:2!2PA@1E/D ;6M]&'L]69 BB(=-S!0GK6$'K.K1_BSR7/#/;<-V^
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M^;WMXMW&26ER'G <-I!*5 SW &N(/'I[ %<$YG2+Q5P]XU"$$@C<@^ E$LB
M4260 01?9.. #?;]QDQ[+7D.UE$/W1!-C&[MRB!]X5GG4EB'\Q("]G3 M]UO
MW&BX9>)V*TI^*IF9.6VYSJ5^E=C6KOM3O'8QG8X[\$J!^ IP"&C=%MDJ1BCU
M4=4XH"JGMSYAB"B#_'Y750G2R#=>#^>P!L]-H'",-%:D^6G;TCBD&IQB'/WU
M3*\;CR>+$%O_<5390@+YHB2_:=.VLIPM9-@,$E2'304ZV$O($4!BXWN?Q7D
M/21CP9)<_\?/[>VFOLMW1L<=5EO(E=Z=P1YO0[$;D*J[LC6#4'CI2J:HVR+8
M*]4O$F<6*0+OW&4(;[BL36527YJ(61ZU*U>,JDLH-%BGE9EH5S@)RA=<VS<:
MN-Z=JNBZ$STI+6V]VS)M#=#"',K6?,FU$V49M>#-MV]X #27_]QZ+ZP_QY+N
M@2HP&P1/LF&G<'<?V)&=T@!V90,G*FEV.<TNH2B#3328Z.8&#8/@1H&*KU^3
M*_F\J%L&&[T4\WZ<G!?IG2NA>S2<$KI+:]AOK0KJ[O/#8=6W?>CQDVS_E 5
M>YT;:>=FIB7- XWF,(./&(#]>K)$#T4Z V5E+"D\XSB!9]P%9 Q!0<OUB2)E
MOX?)Y<3#+ BP!0-CE#]BD36L]TLGY00H4^J)^YN@8CH[09J+ASY?AG4*MQK#
M]M14<RVI^*X/AOT8;H0T%XH2URCC;!)T;0Y>S3@'P;OE-6I2N\Q>>WKPO73#
M(G@(ZTKLFRWCT% JJ0C(8']]T0X'!+1D'O23R&U.A#W"FD2'9B#J3.?45Y)7
M@V>U8'^?V]".NA;T]'HD:-4\K,U9G:!;S$9GN,QW%<%Z@C4*NG)>XES=/  ^
M;XKM/[VSL?TA2*!A%4>N^DR'('\^;+BNME,%(<G4<?2GB_=@"JDFBC"KIF/!
MO0=U%CAJJBE=:++L@\_GC'M.(NIKSP):+?.P$MLD!*UGZ6_'(.'?L$;\GPR_
M-A.X^OALIJ]!V@G_P_&;OYYE\>UI^O%P=.0+\N]O47/B> _:.]R*6C+/Y_.V
MD(+$ (,+PWL8LVJ:_K9@")"-Z=18E^/A*WVK'HQ,7L&_BG'005O2 AEBS0<5
MN7Z.?LTP)ZXS1$6A2*VJW*"*AI*40Z2/HO!*IDEZ^;X,_]R[W$O>E35FUHF1
MYW.  ^#'!?_$-8&&EXFHY_QQ >_+0>2#FF3R,3]QA9CG&KN$P)PF(YZT/+A<
M'65&H<F==.3:?T=]0#S04K<]2+2N7Q@8$S@!IV6@_FF 2K!?)+RJP-/&TL**
MMFI:T?$'\\R^^/53E=(;--=62=ESSR[U_HYGG9:+Y6UW4LM.KKRM%F5(\Y-A
M2W9L3H+;H1G!&2.\@2-MC!'!(&!'&90?B_*FH'">K9>5,0AX'5_A/G"HPSQN
M5#<K>(/N68Y:+BI00\T"LP^DID-+?+W&G RIK.4<FDNJR%75<B3@^E9UG7'9
MJVWT(61KY\3MG#&\B6B@&84E\36H3%)YJ\0>15)@F2YG*/0&<6V;3!PO1A+7
M84<7;E][U]C_DZ&Q?XLP)(A1V[6CP^9HG3PQ#-<3'(.4\WA%!K\)@_AD-\7M
MQ!/?2[P2ZO3HKXA=ZF0.\P]E21)5JF!./10JQ4DL*WK:UUNCZ_&J>@:+O@SB
M[%8B930/-GL7.L7B_&@2/E"_"KT$UI61ID)6"H(%B5L$4S$!M)T67$-.U5.I
M]#=*396V<TX@JI$Y&A&'%BU1,:@P9T\$D_+0!WYZV.Q(5I.%/))7Y0U-.P:A
M'^ZP5>J.!A-"YMQ*@S)T>U$-*)N*LW_CY(61!;"2I)\8,J!T%KJX!5QY/HD0
M<M>$.V(3X8&<62VM.?>GG@E@\'1-1LN-8H_O4C =URCB)?=DIAD%]$T=H+"C
M=..2@'IG!XM@)1U_%L@8T?[_+D#0;\\TGPZ':?YF:D0Y5H7&2H=W3AP]>)GO
MAY?YHDQ>M8R^\1L8$VAD;D\D>AX0->D)'9USF21K?@[9/6S80B Y\T6N7 EJ
M[,HL2FM%.65OX0#Z'?8U2D6TE%1%$'[=7#14_&S[%V98KI2X!@L@_:N:VA H
M=5C>J#]0IFPQ,GQ1QBF#ZUI7SLL,5!C4 $@*9A8I:(:IVU$#4_ZE[;Q*OZZB
M7V.*.CFX+?"D&/RL6S $4B3A52&$FP1H1:5/8X\+$7SVN =+YH7*7-#@,X'N
M)Q<-';=H%#%2%D$?P74S3@<<TZ]<AJ?KW[IFYT3Q#97,0%'E!N*86>IV:!K5
M[?>_Q2V7(BEK?H5)[H5'A;X'5W90,$"OM<(/MQFK)&"K1>/:&==BG<QD:@X6
MI>M(KMC.(OB$PK"I,=4"CU/D#/Z;E22B*/*F7.U)Q^BY^T0UK/+TLZ(!9<!O
M\#8C$1U;5)S_S-TUS],'*/M38F(,FRM59?U]U'V#7C]BMPLN&YT/\<D-\<EG
M=S8^^>WWL&XQPJ6=N\!40M0-IUIP-5 8\Z+2)6E3S[ M]F_N.\5PD)9^:Y\N
M4E8<1K,>TC!71'(L6),RJ&GH;.2Z/"'7-6MZB]@F37-%"6H,/GDOJC@&5:E\
M.BO%=_A&W6PW,'P-)P6:'H: D.\LT+O/ZC5UVZJD)C+H:J-<YZ%^=?Z*0CL>
MS"A$.B6(4W8H?U)(S98?ZT_81D/47>GU-<T-PZC1"-ZQ/[H'&L*PBHHN251N
M&\(&R=$4EB"1=[6%RRF0$E1Q7(1F2Q#Q64>5G=;1X2OZ7R"FE7N-1>$-7<\,
M)8:<'C%V$QJ&<W;I3?> 2(=5@H.MTV=ECM]LUSYR'?ZX@'Y]*V/;\"=H?7CC
M%T&TYN/Z DI"!-1I&WD/2&E8E1.GZ 4%80>:T%;SLB)JD3Z9DL1)-G8:S'.<
MB \IZ<2_)",%VU-5YDH:\K2-S>V5GO"^8QGU%W5-HS&_PEI5Y/DQ)/7_BB'^
M]2V8?B+[X?MG!R_>G_UV<G[QZNQ]\O:7Y-W)KV?)^<6'LXL/YV\O3MZ\^<_D
MS=DO'Y*7;TXN_A_\_&@]X.Z#Z;?_XF!_@^V'2S#9/[XS1^E!^EBG3Z=/'STY
M3J='SZ9/#XX?/U/9T9.GA\?J\+^.O_M*]F+/%E(D\[O;&Y*#[&9X?I'\<?[A
MXNSR,OGC]=G[L[>_C"/+33(*J']2UN9+SS."Q&_"_(A==$X-/W-);Z] 'U]_
MS]?:U#U;^S<]MKKQ_0]M_HX;\KE+B3U7=^'@<K6H]7/[CQ>(K)FKY7-3T!G0
M0R]BW@;BX@7"P2+TG2R)ILE?>XK<VV>J;& Z36;?+%_OT5<_-MGJ=T>'>X='
M1VN_WM\[6/O=MH8]OM6P/]).\&[ AM<+5?SCNZ/O_/TGN?Q\/SF@@[;C_3T_
M/5Q\PA^'0@D5@.Y)\B%^4T%%5'+Z]K=W)Q?_Z>@VV*^.^#D@=64K>QC]].$T
MUY_FV>NSDS<?7H]!T3C=>SC3.W:F*Q*8SO3EDM-=J<RJIO\FOV+O%O@O0K;U
M'?.WW4@1:DVY> Z_3:@,,,$]>7%'MGA8VWE'-NWR]W?CY%==4%;]*??DN7LL
MYV%V#^SZJ[/K5[JJ3/HQ>=5^U-OG+W>>75^HN>9-_MS&#OG^_$@V7H_MV?$3
M?L[ZW,YC#SZI_1<'!ZONBL^X>[[47_7D:_FK_FQ^P^'Q,!RL9__Q^OSE^8?D
MA%8 ___]V9NSD\LS=+6>OCDY_^WRS@<J/KP^OTS6+NL;WX'AH8]M.X?,09 9
MB;Y-EE)]SIEB I?$X$C)3A#UP.HFA"YI)[7)C*H(4COHPC:8+9;,M&UO,.YJ
M*.F'1XLNXV_+6W7WH[,49#C9%I<;=Q"<??X^B3E&1\-B3>F+->6J0T+JF:KK
M<B5/GPJR+> :%>[7MD[20Q->NNS0**\^9"9V//PLZ!\T1*;1LYJ'6_$7;\7%
MVS^2#W@S?GG[_FQK=\,4KJ0C:A4W;YM6849I.3<(0D72$ .#IF"Y]BX(%B)A
M$_J6LF#Q7]YN=FAG1%KUP1;J/O?[ZSZW6B*_WZT']!U1?"Y1MW6[1_C/$B"L
M_UK_?W?Z,M/>' Z'4$[#MO?GONW] *A&DHJD4QO5OV..(PE2Z4'@IFZS)?GW
M?D72F& !&C;!*1B_PJZ@]@7_X1NI-F[I2S48NHJP!VQ1FDMD>!>\*-A*^O4Y
M%B+QKT^^H*1D:/*=(\:=C=^BE-^/I'P?RV'X# )3T"!J@FRSNN?7J*BYHDY!
MB5CH LPXHJ^%KO[55LMN-3$JBI6&EQ0ZZT)J(D$YH.\*T0@QO=U^<EMB'2=Y
M>872M]+R:U_[)IGPW*.7\7A=MQ!7660:/4=,[&O8A 778I03O$K=&E06\844
MVA'=;^3C_45,E.Y'QBZ_&/>^N)*F+,&O[SXO/QH.+W\G9?! J)?4&VH(3%RE
M"!>5Z^Q*8-.B.CO!@ H;TB"6%3>MHC5@9?45ND>HM16U'DO3J@6RO5:I*PZ9
M"]H5O\*R<T^%KJ-BQFS=S>_N$^#Q< CPO;>*3\DJWB8!8@D/FA@1H!"7 &&#
M,E4IZF;FRC0L\M%QZ (@0R4@5!A(7Y72F3VP@P*BAO<UN0,)IFH,VQD[;/(>
M@/R6-]WV!3&85'B?QJ@<3S3H*5,<=@:;K/&?5!Z'_QS''@+'LJ6VCA%\"*Z2
M=UVZ;85@EWQW:NK6-+8F&RZ$;Q7NP36UBJ?3KE>T*()Q@TT>)[;G/3W6-MS'
MC. ,\!Y?X7Z-!6N:@#1=-U(T-:]U+5";,U5IK%/0?4"<"@;,L;$\#27%-^..
M;Q6.FU^V0 $JR,:D\3F<8PLWQX\'6Y#L8(XF[UV^')R?EBA>;EYF#>TM:V)C
M,N_&'FF[IJHGH/&Z]4"2B 9.&?Z2_(\-IA$QC>$LW1?,SQFA%4_-GS\2,RA,
MJ=:,!@!W,M4$^"(8%LB$QMBS$H[-WSC_)KR8J5Q@#%RR?B)](!O-_=CPSX\&
M$2AM2:N0-=P'AD*DXC#Z)])=+0VGZ5/WY[@/@F91UC5!$E9 MO!R#T5CY1F*
MNX;J;AGUC :A7.LRI?:#B)X&[VD,ZX^^J2>2*4&4!085D?,*DKD\,7:M3*D/
M*,O6OU$\/CG<AGC\%H!-?9=A3=U8J)J(YS@D/:3OD!8VJM[\(!#)S"Q6]'!G
M2H:0=23K5/PD=?"[^\?\#=".;G',MJ9K\S&/N^?<!T_-T'N(9>@Z+>!3*7M:
MY3/"#T3Q2)R*>T7%?HWQ9RZX9Y1L-4XKU0*S OX3(P.,/6Y0 B9KFQHT49FU
M^F_P;]N&W%<3UE1H[?%<<W4SMG@N;<4M@^F]KH/Y4I[!"0EL+SRTF50?$E+V
M7_S9?)2!Y)8,F+]\ VBF6XF1)VO8RY3@-\KB"A3U ((,[J27&-RL-10(8*%<
MFS)WTH';9(-> O]=\L]QK,K8)_@S?^$)7!28$MKGS<RU/"=5A+$^ND\H>.9:
M%](#[PH!2*<*A1<9"<H@&KG*B5UM'I*C3:"Z+Q.T%!8+G?,7A;X"ZB%/" 5L
MV?&J$*R64!QDK7I>RN<$W _O^,SC*SSQLZ^#K;:H4P+FS;LE2 '.(M/P!2PF
M9:AI1/7FH=N"-L3ABB_P8=]/.]- ;,%,<C.Q>U#G"EEI/,-4AG6=#TR![DSI
MX5O7JLV%1B:D_LHW"(-@P=\6E;E6EC2F*D<-?@X?PGB>PL0]C@U?[-SNOH+Q
M#6"T_IJ"@1P@NLR$"\S2<^SE*2%'$\ Z?@1R+M(0L%8;3372$,@MP0;O"?"2
M5Q$GH,[T7AD]8724@V>/GR0[)Z_.3D;\X"F8Y'GR'M=3NQ\]??QXG'PP#>@&
MOY^?.XVE[Z?/'A]O&.C9LP/^]DP\!\E[C1!'-*5S!C&X9"5C20_MG+T_O[1S
M.YG#B:38%H]N)ZR/D3=0'SE)I6W2+^PFP<W^32,\=)Z\T6B T7"__/;&CO9'
M67T$Y>4D0Z)U_4Q@/I4R:),FB&#N8@MN_-_PXJ6S%OU&-;P-[GNPK>_LC5_W
M0.#T_0,=I0CBT_>[MY2Z#=NQYOO?8([S=LX3V#A2]R#Z?G/VWZBEWN8W,/]U
M/WBC)N*E.2^R%GNK;-@&YDOKOH8!]$(3_^ ^] H]3OX&],Q.433G$E/./D3[
MAOW*=F.IN +[LGI*)MM(23PT,HM_1S_>$F=9IX9D25M[\GY7E8TX*ON>@DG"
M557H.^E<5Z%1D)3)[P99KE')ZQ;XTLHI,1H2G$L6'@U_RC3N.B.@C:&+.J#H
MTYE:8)[4X8'="'Z0S_*TS'2R U*C%,^)-$?CWYPZ-SXZ.;N3DUL&= JBL&SZ
M9D],$6Y#QH@HXLJ1>3C7[=C%"#@V$+-(LK+R,F6+8YQ4;4Z? 7O$E";Z&@9J
M<R]W[[YL^P9X9']9N8U$&QVH/;<RL!C'/L![?X[G&^!SW>)X+#Y7S_E87P;Z
M%B+0*@)+XZB?O3*QPRMP9U'S&/=7G]D! ]W]P_P&.%9_S1^)EPW4_Q+DG^^!
M,[6=S-*R;NX4!E2_ V5]B,^F]G;BAJ9VZ,.^=1(1M@5>8Z0U:JI"@&QDW4F[
M(4HCTJ" 7TFYK'V+JFU&A(TXR#<907G#>^&>K (<$Y9V7P*+-,\@O/%,SPNO
M< J7='AAWM7FW7EEY:-QR0_?'SU]X>)U&(^1KL_L':#&4N1@E&8K#G1?#%P/
M=-OU2/;Y]L@DIH$)=-&^[.Y3VH> IM#^YYR;+DUEI<3(T&U*_1RP5UM?XU7]
M"54N'-/,)RUH?;3%M'44ZL1^:G@*&#Z%%PE!^(8WW?'((-I%GPP&DVP$UK54
M7.1H'R$1>W]N6?CH4C>:5 NR/6M9V+,M<#"[2T:.D#)'-P\=?IICCSJ1X37%
MQESW"(EL8L]A5/*; $+98B#:OC@!!VN+0)@$/6IO8@TV#358FR5RQS%F][?5
MW'Q-6LB)2P'REJIM!<!Y(D*>Z#887,X21UR)7=4SZNF S->V<6#RY+^6OG61
M_342,D5K_?W[,D_*T!(-MGA$4368<!(Y#>F^;=DL?(H':,_(=5.+#[F3:LLU
M"1O'7672P:%C4D' Y?#D42V.CAXV+V@!=HOH?">;IX<RA9L&N4C<VXTS0/O7
M$;%KU%<R::_!*V*E TCP6N6<+L=<UD_C!N5!7FF5+0E3O,E)7PF:@+45]US<
M<),PV6^"Z<\JPTZYOMF/;9-"OT<QZ)]Y"/YM"/X=/H#CWYJ9U+.RS2E*05T7
M;S@ Y>P> <=' Y5IFLAQ]68:7](D1 R/9&52EVRQHC(64SR0-%Y"N+@W,,IR
MEUK*'AY(?T"<!S8*$IA4=[,[+Y?!T^[@V&6B2':>R&A<7663@60EFYKX6$Q'
M>'.EK\N/6B16_-ILM![8.FIBS&E);%1=EV*'+.# RHRF"ZHL-@;S02/L8%NL
M-7H6E=1/!HT'ZY#I8,9,BE/1G&N..Z/U1Y(#V$ R#GP&H4<Q4#P4]S3BG3$'
MYQ9D) M /S9SX!VZTS()9T>)^F.I'L!-I1Q#,)Z)-6>41%J78]M1RO;.5)1F
MZ=L_39:AE01,]IR5;^X!_9G<+F;Z6)A <^V4)L >2#,KQ6,>'NRBSU=.B.L2
MJ$R5FM=&I;%"]"OL/2Z*$"DL3F\KA]$)GLY@UTC@<+-)RE1"-[N\'+:AI-;9
MTL:';L'J+91&K %YR<6..FQWD4AE&V9&3Y-WN@3+/'DK7;8Z">ER+^A> 9W$
M[9[%_E&?.X:[9,/V:WW;Z +_^1SS?W+.Y0!RS;U>1&X9\O^$=O<I'"@0,L9<
M.'I&@9"#1\>'8RY+LH:LN%+JOU(;&VT:THO[A.;$'PVA0<W)BC?,*=@P.UW0
M35WQ', --AB[*ZO ^.*^<^YQI OB_JUK**,_F9J<<T&G62[8EX&)^V!:2"#P
MG?MA[(P.<GLQW6%G>C.7P> $B?&0M3<'SE 99N4D#8'K!.\-2@1<VF:F)]&J
MX E:U-Y?=$5LU;6*@3Y7)D!-@>2"W,)6MB$=FQI>SN? WM%9)"WB<TEZ!#LZ
M5Y6H'4$R0T\N0_(;.N *Q??OI(!OJ>#8UGX</MT]V 55&J[E!;E^7ZF/&&H\
MA:/"NC]ZS/[XV>[!T2[^%!=V6;;!SZ6')(9C?6')X?[ND]T^Q*B[)@VVT11^
MC32X*$& 2T5-E?S")2:XZZW91C.%58G0K7:+]?6BI @93G8LG,YF^5*D;"%K
MB]E6H>8<AXY*@8).,93>Q?UD&NJFI"0E(%1M)![0_PBW2Q1EB8$<>NW[S<O;
M,2/\!=RDGKK8(/"$/ME=,M;),_ZOMA)]&6L<%LIGZ;%WIY#"AZAN-6NK3A_Q
MP/\;UU.)&6-@=N1_X++<?.D#&5QPHJZY>3$[TB?:U8RLAEUP,^."*O?5C$"@
MXAZF<\PRPH"+%.SB3JP4B#"!-#Q'Z=K"^TC*^YRGG31@RC=LD>([6@F^" 5)
MO:.R"R%]&BU;:NC&[9-II793KL&F5.P9*Q=X=&UAN,&T[$YTBB2^;-<W:4<O
MM.BBBER44P?M$7V-C 9-.972YZ -K:GKEBG 1?UK&W6P?3KQ'5'9TS*P(Z_)
MCDPJ13:YLI5 FV0#66+JQJ;/=F//,U6INO96<*T_8?J2_QANV:0E38$3*<>N
MSBF1P7)[0#9[TN3(KFAKV9Q##P1[?_%*+'*5ZN -MKEP=VJD,Z #UYFV&'!L
M*WJ &Z"Q-8@IH,N@8HH 7?"=.:@K!==381L"%+EPK=$1A@,"R;1S6DXSJ\KV
M:A9?)J%SRG;E16+W;D,&>XG%=53,5^;75J?JY4#Q4?Y5K6< 4O+IH*3D2>92
MJZ;)&[.U]FI60L*4I/(..)$N.AQZ[!I7P\7 !+A\R<G5*]@$Z_K^21\B<1XT
M5##.=87H4$::#S>$]/\*-3@JM,OKH/N:&"#<Y@23R!C="'[(D=; "6(OJ1\[
M7I9+RD7^0'EF]B# _%--75)=;50)S$Y(PL>9F<K:!'?^<CP;U.4X+5&2;AGW
MYM+W9=MNA7'_#"7Q%*[1"3IWD68O2LQ/+F=F@B)TNU%!ET@A[I3^_)[ 4V/$
M8>U=E" <06B"D!Q3J[-:2VHAW.2Z897&9D6Q+,2.NFEN2/L5;(&P.L06>01>
M=QQ$!"Q5JT^E.@3^N *=]UKQOZTEP#4\;!(XJ5K;-)N (3@%/\AW[9:$.T^S
MF->H4BY*#<:PUU-$:<B8"U$<@[<@L=HYIP=Q\-.%-,5-_A"<VQ"<.WH(SMWZ
M3J^$?N+ /5]H*@[#/+<Y"'K$?\@I9P@F'(E<PM_$<(Q9.+.!K)Z0_ /"%T]?
MB29N8>K9V,;D0/?5H#T<C7PY%@79I$6PO&),NO>";N'*:U9NV7U(- KZ\FU3
MEA.X_E"%U,9<SIV-'DNJ./%AMCG#F*S@STI//@;@#, VQC9!)(;*\^@SUK.M
M)5#(17Z,4^;+6D;<;0$=.IM33VG*FFC3&I<17L<8@3Q,G<L?<"G^!4M/#:.'
MBET: 'F@"T%?P59T;>BQ^\:9[8'#QQ5*!EZ'R+Y J2;/]UCR'5=#]\F>KQG,
MQN>P:UVO/'DSB[#^7/X+NF8P#LZ&O/4WH=K?4!2$^(@*]R=L\ZMB[F7Y#4W4
M>F:<\X?Q1;H8*N(8$,PX>T!MI0-/&5M6Y)^GM;<5Q;U+ZWC'U?)"<()^E9S$
MD&J52YBC42:/:P"<E44( IVJI>A8(D?'%SM<8!VP$+I;[+&CB6\D99M-H/OS
M _PE[B1YR5:^_>/ENY/ L^8R&+I)"^6<RC)Y2U#@C!-$-:+$!5O)'>B ]!-7
M!7UMB"BR,FWGE@I#H,LP[LY6-":GET4MKL%5$14^;6FG*9VWB>9,N2)82-H(
M6U.%@#8%,#OQG<:CL'E>6NK_@L3'MX&_T=>"C9,+ZP'F(K+W%KPD>5G"U68.
M=^F1)#AC#G8-CRT<!V-'TF'=T9-W0/57RW(EF%P0/HG,!^V"T:QN@?[\L=LD
MWNC,$GJTU4CIZ)Q;NBWF)LL5\O]P$U4%LJN*'7X[3$W].3#ZDZY2KL@)_.%1
M1-H&I9Y8+G7QYCV1K0VG\0[@EA'V^15L 8%-6@D[%B9-^$Q6V-+&\'8&4%Y%
M6>QZKD@]Q3'(0#8)^L;)I0A$@;D3JRD>J^%U$E;VAL(>E-=R?* 'P3RREB/*
MF-T1R%9*YP!)BA40A$^%8@+_B<$-6JUUWTCID@6<0J;&+5QYT!$3NR6'L;^6
M7#O( 1T_4' ')N0^;>+(!0N4528DH9U5:P^AV@C=;BH$S)L10TLQIRY9+T4>
M;RL_B*)NX.*(-.CQ$._@&9$.X<77B-X6,@87+1$M974<E$#H-PO@OA9.%</4
M'<D[Q4#Y>$/B5XC9JJRU*?=-J+IG\9XE7\(-4J"Q[[[]E&NN R_[KL Z/@,/
MW M-?1@ Y:2IOR0\D"%$:%< 2D.'D4#!43)'@&'2U>!M#A\J:O*KF&:9F8C'
M.[K]?U^^HK8W@^.U'95D1'R&[XQ3Z[V*N@;16=0^R?&.LP<#NSOBPZ[4)B43
MQ2LHJZGJM,>F%L1MQE#I8X4^=94Y4[$;9/RMGH=8\ QP#%;ZG!%DM<,$#2O6
M+*Z4^Q!TSO(&/?'C9 6@UB>ZVO6^+73R&K8:]?=7V,N[JI.=_W- 3;A'=G_C
M5=O,>42Z'5L42M#PYV7K=AP#P]PA 0%$77A4-]W!+-*SZ[V OPW114$[;N?=
M:+FEC?N5IG@P#&#] P;6K[>9@8)5A[;IAMQAY$H3K:SG&C/8*!]Y3"6%H'5.
M25M;7_IKX1(P\=GF8'PV)'</J&H8$-]$52><&+[-R&UO;A/G]E656I,)1$Q0
M+50JN224Y1 E-5%")6N\1&M1:A/F",W*9$YZ+KL*;"J"S\"D^*YA9];<*J7K
M^S7<,R(=!@SX@414WT<X:5OD@Q<VD8#"9-RH 2'D."Y !D0\U41@@=C3ZOKZ
M43Y4.!*E TC6MJK8Y1K5<*SB!]R"W!XB9?LOCN]LI&P(?& 8==_$![@/W+8S
MC:)Z*6?4>1,(;S((A(E&L#CVG6*C%) RDF/J'.Q31@M @,<$<U3K3, D!; \
M)RL/X^SB%V2PA"JY+@VY*7M2E5RO(=LK@!YD)QG[U2UF;XT08F[:]T!B#:.H
MB"CUK$#0P*TW,B*]O5-DBGUSO,.YI[7B>+,%OZX?A T-D7=S&>-@.'R-NJ>]
M3Y3RK<DU4 60'/0Z,B]=KPO;YBI._P[+VH-X'Y7;22H40^+8&]J_CEIC*P\V
MA3LMY>[!'1E&J875ZMYBK=9O5-R2;CE;+KXGY/0M"]"Z$)4)$0#9-+7UGPQ)
M$[M '/X#E8'ZSVTE:!R]O0>T-(R$9**E7RE4@"?S1MT,AHA<\C!',GRDDE#L
MA!YJ("\)CKE"_:![&BD0"(]!788DZI6MI#=;H<[9"5SD/"NE>H)KW"R@Z+V(
M/ PCWY=EO8,G> 6'.!CB@S\\<((DF- 3LV3G:3,;!;7GIO&Y(YZS43Z<R_5T
M'F[YL2LD8ER'#B]T:!?DB,Z$N%6:EE6F''KY$-.23^+4J&&"2W5SE E.@7/"
M<&.=HM2!J373OFRA-3P%#\QCXXJ50S7-4AGWA5T<5W'=5LBS-I\:3;@(.P>/
M_^ZM?;+W]%:HEBM.DJ9</-\]WL.3(<CK5.7"#R>JUCC =S\WVXH\WO(:+_[<
M-5YS9QT,#"?QQ30U-5,\1#C"1X(:P[-;DXSAD6&,0]\CIA$$Y.8@=T@12[FD
MKYY90SJL%'3 E'%AJ*/.7GB.51 /VR@7BSF7MG\K?#]7)K<IC3;]UR77C7W-
M)P@(;/VP,N+&>;!1!;37@ 3^*!E!4@)P\(A 5%81;S!KQ_ T9_#XW=<H#P>4
M^7N*L5-=X<79:M1MQ2J96. E&RSS\V0JDFP!]W$WTY(4SA6O$"))87*8N:(\
MQZAYM6VHIPK/L\<4&J', @_+&J>Q^N0&B0\S4[H'=#J@O)??+1:A9<.<P# X
MSQ,)?$NW80(I1?K$>J%RII:Z\Q#B:D9^S&G>4L>;B+RJ()S7!+%ICJ., V&%
M3E#NHL,IQ0Y?TR%4=\+;00(/^7>_&#!GF#CAP^I;"!LN:768N]+1"NX)S/ZP
M6@CZ'>_#8Z"(!5X+YXZUH-)4A&A]HF/L_03*ENOUEWT.!I SU:0 4FZKS181
M#T7E\J)D@B%_P,@)(5RC-:GU1]8.9;Q[0BB#Z@5'=.(=[JM9#S5JO5A8NB93
M3CBRPVDRC<4IK^_)>0VK=1<=&*8,2$OM&T5ML6WMC6AS5EWSU35_,F5EWVUY
M3YS[(?4@^N^CA]2#/W7-:%//+Y(_SC]<G%U>)G^\/GM_]O:7;W_K:"+C6,-$
M">54V0[_$QU5FG40_@TU(/#).X0GL/ZR=:[XXUM>MIXSE8_0?16!-OJ1HS/>
MM2]KI,6N7$>L MS%AO5J4>OG]A\O$'4@5\OGIJ#]HH=>Q+-XM.HQHQ?RUYZ
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M\YX?R7KYNE;5-S7A'IPSMW'./-[@G/EQ4F9+^)]9,\]__O]02P,$%     @
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M-5X54^F$[/)E+8UP17LG*D3Q38DT"G<N=%&(3UBCBQ^$TDF3-\Z+ WPC5Y"
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MN2S"G::Q0#.'+@6+#J"D26=34V3\C4'(RYF*/T&?I6=J%/VT[6EW+B2*KJG
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M\?:P]2OGI-M6L1^%__CWB/_#X7\!4$L! A0#%     @ B4O]6M*6BOK2&P
M9YL  !$              ( !     &5H=&@M,C R-3 W,C@N:'1M4$L! A0#
M%     @ B4O]6K6&F.!K @  '@<  !$              ( ! 1P  &5H=&@M
M,C R-3 W,C@N>'-D4$L! A0#%     @ B4O]6F9&X 3["0  ?50  !4
M         ( !FQX  &5H=&@M,C R-3 W,CA?;&%B+GAM;%!+ 0(4 Q0    (
M (E+_5J9C53.M 8  /HP   5              "  <DH  !E:'1H+3(P,C4P
M-S(X7W!R92YX;6Q02P$"% ,4    " ")2_U:Q5W&8O0<  "'Q@  %P
M        @ &P+P  97@Q,#%C96]O9F9E<FQE='1E<BYH=&U02P$"% ,4
M" ")2_U:[E#51/1$  #_P $ '@              @ '93   97@Q,#)C96]S
M979E<F%N8V5A9W)E96UE;G0N:'1M4$L! A0#%     @ B4O]6O'1Q5?R#0
M=S@  !\              ( !"9(  &5X.3DQ<')E<W-R96QE87-E:G5L>3(Y
>,C R-2YH=&U02P4&      < !P#B 0  .*

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>ehth-20250728_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="ehth-20250728.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
        </entity>
        <period>
            <startDate>2025-07-28</startDate>
            <endDate>2025-07-28</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="c-1" id="f-23">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-24">0001333493</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="c-1" id="f-1">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-2">2025-07-28</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="c-1" id="f-3">EHEALTH, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c-1" id="f-4">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="c-1" id="f-5">001-33071</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="c-1" id="f-6">56-2357876</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-7">13620 RANCH ROAD 620 N, SUITE A250</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="c-1" id="f-8">AUSTIN</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c-1" id="f-9">TX</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-10">78717</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c-1" id="f-11">737</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c-1" id="f-12">248-2340</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="c-1" id="f-13">false</dei:WrittenCommunications>
    <dei:WrittenCommunications contextRef="c-1" id="f-14">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="c-1" id="f-15">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="c-1" id="f-16">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementTenderOffer contextRef="c-1" id="f-17">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="c-1" id="f-18">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="c-1" id="f-19">Common Stock, par value $0.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-1" id="f-20">EHTH</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-1" id="f-21">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-22">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
